Thermal microvalves

Information

  • Patent Grant
  • 8617905
  • Patent Number
    8,617,905
  • Date Filed
    Monday, December 5, 2011
    12 years ago
  • Date Issued
    Tuesday, December 31, 2013
    10 years ago
Abstract
The movement and mixing of microdroplets through microchannels is described employing silicon-based microscale devices, comprising microdroplet transport channels, reaction regions, electrophoresis modules, and radiation detectors. The discrete droplets are differentially heated and propelled through etched channels. Electronic components are fabricated on the same substrate material, allowing sensors and controlling circuitry to be incorporated in the same device.
Description
FIELD OF THE INVENTION

The present invention relates to microfabrication of microscale devices and reactions in microscale devices, and in particular, movement of biological samples in microdroplets through microchannels to initiate biological reactions.


BACKGROUND

The complexity and power of biological reactions has increased dramatically over the last thirty years. The initial observations of the “hybridization” process, i.e., the ability of two polymers of nucleic acid containing complementary sequences to find each other and anneal through base pairing interaction, by Marmur and Lane, Proc. Nat. Acad. Sci., U.S.A. 46, 453 (1960) and Doty et al. Proc. Nat. Acad. Sci., U.S.A. 46, 461 (1960), have been followed by the refinement of this process into an essential tool of modern biology.


Initial hybridization studies, such as those performed by Hayashi et al., Proc. Nat. Acad. Sci., U.S.A. 50, 664 (1963), were formed in solution. Further development led to the immobilization of the target DNA or RNA on solid supports. With the discovery of specific restriction endonucleases by Smith and Wilcox, J. Mol. Biol. 51, 379 (1970), it became possible to isolate discrete fragments of DNA. Utilization of immobilization techniques, such as those described by Southern, J. Mol. Biol. 98, 503 (1975), in combination with restriction enzymes, has allowed for the identification by hybridization of singly copy genes among a mass of fractionated, genomic DNA.


In 1977, two methods for DNA sequencing were reported. These were the chemical degradation method of Maxam and Gilbert (1977 Proc. Natl. Acad Sci, USA 74:560) and the enzymatic method of Sanger et al. (1977, Proc. Natl. Acad Sci. USA 74:5463). Both methods generate populations of radiolabeled oligonucleotides which begin at a fixed point and terminate randomly at a fixed residue or type of residue. These populations are resolved on polyacrylamide gels which allow the discrimination between oligonucleotides that differ in length by as little as one nucleotide.


The Maxam and Gilbert method utilizes a fragment of DNA radiolabeled at one end which is partially cleaved in five separate chemical reactions, each of which is specific for a particular base or type of base. The products of these chemical reactions are five populations of labelled molecules that extend from the labeled end to the site of chemical cleavage. This method has remained relatively unchanged since its initial development. This method works best for DNA sequences that lie less than 250 nucleotides from the labeled end.


In contrast, the Sanger method is capable of sequencing greater than 500 nucleotides in a single set of reactions. The Sanger method is an enzymatic reaction that utilizes chain-terminating dideoxynucleotides (ddNTPs). ddNTPs are chain-terminating because they lack a 3′-hydroxyl residue which prevents formation of a phosphodiester bond with the succeeding deoxyribonucleotide (dNTP). A small amount of one ddNTP is included with the four conventional dNTPs in a polymerization reaction. Polymerization or DNA synthesis is catalyzed by a DNA polymerase. There is competition between extension of the chain by incorporation of the conventional dNTPs and termination of the chain by incorporation of a ddNTP. A short oligonucleotide or primer is annealed to a template containing the DNA to be sequenced. The original protocols required single-stranded DNA templates. The use of double-stranded templates was reported later (Chen and Seeburg 1985). The primer provides a 3′ hydroxyl group which allows the polymerization of a chain of DNA when a polymerase enzyme and dNTPs are provided.


The original version of the Sanger method utilized the Klenow fragment of E. coli DNA polymerase. This enzyme has the polymerization and 3′ to 5′ exonuclease activity of the unmodified polymerase but lacks 5′ to 3′ exonuclease activity. The Klenow fragment has several limitations when used for enzymatic sequencing. One limitations is the low processivity of the enzyme, which generates a high background of fragments that terminate by the random dissociation of the enzyme from the template rather than by the desired termination due to incorporation of a ddNTP. The low processivity also means that the enzyme cannot be used to sequence nucleotides that appear more than ˜250 nucleotides from the 5′ end of the primer. A second limitation is that Klenow cannot efficiently utilize templates which have homopolymer tracts or regions of high secondary structure. The problems caused by secondary structure in the template can be minimized by running the polymerization reaction at 55° C. (R. Gomer and R. Firtel, “Sequencing homopolymer regions.” Bethesda Res. Lab. Focus 7:6 1985).


Improvements to the original Sanger method include the use of polymerases other than the Klenow fragment. Reverse transcriptase has been used to sequence templates that have homopolymeric tracts (S. Karanthanasis, “M13 DNA sequencing using reverse transcriptase” Bethesda Res. Lab. Focus 4(3):6 1982; Graham et al., “Direct DNA sequencing using avian myeloblastosis virus and Moleney murine leukemia virus reverse transcriptase” Bethesda Res. Lab. Focus 8(2):4 1986). Reverse transcriptase is somewhat better than the Klenow enzyme at utilizing templates containing homopolymer tracts.


The use of a modified T7 DNA polymerase (Sequenase™) was the most significant improvement to the Sanger method. See Sambrook, J. et al. Molecular Cloning, A Laboratory Manual, 2d Ed. Cold Spring Harbor Laboratory Press, New York, 13.7-13.9 and Hunkapiller, M. W. (1991) Curr. Op. Gen. Devl. 1:88-92. Sequenase™ is a chemically-modified T7 DNA polymerase has reduced 3′ to 5′ exonuclease activity (Tabor et al. 1987, Proc. Natl. Acad. Sci. USA 84:4767). Sequenase™ version 2.0 is a genetically engineered form of the T7 polymerase which completely lacks 3′ to 5′ exonuclease activity. Sequenase™ has a very high processivity and high rate of polymerization. It can efficiently incorporate nucleotide analogs such as dITP and 7-deaza-dGTP which are used to resolve regions of compression in sequencing gels. In regions of DNA containing a high G+C content, Hoogsteen bond formation can occur which leads to compressions in the DNA. These compressions result in aberrant migration patterns of oligonucleotide strands on sequencing gels. Because these base analogs pair weakly with conventional nucleotides, intrastrand secondary structures are alleviated. In contrast, Klenow does not incorporate these analogs as efficiently. The main limitation to the amount of DNA sequence that can be obtained from a single set of chain-termination reactions using Sequenase™ is the resolving power of polyacrylamide gels, not the properties of the enzyme.


The use of Taq DNA polymerase is a more recent addition to the improvements of the Sanger method (Innis et al. 1988, Proc. Natl. Acad. Sci. USA 85:9436). Taq polymerase is a thermostable enzyme which works efficiently at 70-75° C. The ability to catalyze DNA synthesis at elevated temperature makes Taq polymerase useful for sequencing templates which have extensive secondary structures at 37° C. (the standard temperature used for Klenow and Sequenase™ reactions). Taq polymerase, like Sequenase™, has a high degree of processivity and like Sequenase 2.0, it lacks 3′ to 5′ nuclease activity.


Methods were also developed for examining single base changes without direct sequencing. These methods allow for the “scanning” of DNA fragments for the presence of mutations or other sequence variation. For example, if a mutation of interest happens to fall within a restriction recognition sequence, a change in the pattern of digestion can be used as a diagnostic tool (e.g., restriction fragment length polymorphism [RFLP] analysis).


With the development of these complex and powerful biological techniques, an ambitious project has been undertaken. This project, called the Human Genome Project (HGP), involves the complete characterization of the archetypal human genome sequence which comprises 3×109 DNA nucleotide base pairs. An implicit goal of the project is the recognition that all humans are greater than 99% identical at the DNA sequence level. The differences between people, however, provide the information most relevant to individual health care, including potential estimates of the risk of disease or the response to a specific medical treatment. Upon completion of the HGP, a continuing effort of the human genetics research community will be the examination of differences within populations and of individual variants from the defined archetype. While the 15-year effort of the HGP represents a defined quantity of DNA data acquisition, the future demand for DNA information is tied to individual genetic variation and is, therefore, unlimited.


Current DNA genotyping technologies are adequate for the detailed analysis of samples that range in number from hundreds to thousands per year. Genotyping projects on the order of millions of assays, however, are beyond the capabilities of today's laboratories because of the current inefficiencies in (i) liquid handling of reagent and DNA template solutions, (ii) measurement of solution volumes, (iii) mixing of reagent and template, (iv) controlled thermal reaction of the mixed solutions, (v) sample loading onto an electrophoresis gel, and (vi) DNA product detection on size-separating gels. What is needed is methodology that allows for a high-volume of biological reactions without these existing inefficiencies.


SUMMARY OF THE INVENTION

The present invention relates to microfabrication of micro scale devices and reactions in microscale devices, and in particular, movement of biological samples in microdroplets through microchannels to initiate biological reactions. The present invention contemplates microscale devices, comprising microdroplet transport channels, reaction regions (e.g. chambers), electrophoresis modules, and radiation detectors. In a preferred embodiment, these elements are microfabricated from silicon and glass substrates. The various components are linked (i.e., in liquid communication) using a surface-tension-gradient mechanism in which discrete droplets are differentially heated and propelled through etched channels. Electronic components are fabricated on the same substrate material, allowing sensors and controlling circuitry to be incorporated in the same device. Since all of the components are made using conventional photolithographic techniques, multi-component devices can be readily assembled into complex, integrated systems.


It is not intended that the present invention be limited by the nature of the reactions carried out in the microscale device. Reactions include, but are not limited to, chemical and biological reactions. Biological reactions include, but are not limited to sequencing, restriction enzyme digests, RFLP, nucleic acid amplification, and gel electrophoresis. It is also not intended that the invention be limited by the particular purpose for carrying out the biological reactions. In one medical diagnostic application, it may be desirable to differentiate between a heterozygotic and homozygotic target and, in the latter case, specifying which homozygote is present. Where a given genetic locus might code for allele A or allele a, the assay allows for the differentiation of an AA from an Aa from an aa pair of alleles. In another medical diagnostic application, it may be desirable to simply detect the presence or absence of specific allelic variants of pathogens in a clinical sample. For example, different species or subspecies of bacteria may have different susceptibilities to antibiotics; rapid identification of the specific species or subspecies present aids diagnosis and allows initiation of appropriate treatment.


The present invention contemplates a method for moving microdroplets, comprising: (a) providing a liquid microdroplet disposed within a microdroplet transport channel etched in silicon, said channel in liquid communication with a reaction region via said transport channel and separated from a microdroplet flow-directing means by a liquid barrier; and (b) conveying said microdroplet in said transport channel to said reaction region via said microdroplet flow-directing means. It is intended that the present invention be limited by the particular nature of the microdroplet flow-directing means. In one embodiment, it comprises a series of aluminum heating elements arrayed along said transport channel and the microdroplets are conveyed by differential heating of the microdroplet by the heating elements.


It has been found empirically that the methods and devices of the present invention can be used with success when, prior to the conveying described above the transport channel (or channels) is treated with a hydrophilicity-enhancing compound. It is not intended that the invention be limited by exactly when the treatment takes place. Indeed, there is some flexibility because of the long-life characteristics of some enhancing compounds.


Again, it has been found empirically that there is a need for a liquid barrier between the liquid in the channels and the electronics of the silicon chip. A preferred barrier comprises a first silicon oxide layer, a silicon nitride layer, and a second silicon oxide layer.


The present invention further contemplates a method for merging microdroplets comprising: (a) providing first and second liquid microdroplets, a liquid microdroplet delivering means, and a device, said device comprising: i) a housing comprised of silicon, ii) first and second microdroplet transport channels etched in said silicon and connecting to form a third transport channel containing a reaction region, iii) a microdroplet receiving means in liquid communication with said reaction region via said transport channels, and iv) microdroplet flow-directing means arrayed along said first, second and third transport channels; (b) delivering said first liquid microdroplet via said microdroplet delivering means to said first transport channel; (c) delivering said second liquid microdroplet via said microdroplet delivering means to said second transport channel; and (d) conveying said microdroplets in said transport channels to said reaction region in said third transport channel via said microdroplet flow-directing means, thereby merging said first and second microdroplets to create a merged microdroplet.


In one embodiment, said first microdroplet comprises nucleic acid and said second microdroplet comprises a nuclease capable of acting on said nucleic acid. In this embodiment, it is desirable to enhance the mixing within the merged microdroplet. This can be achieved a number of ways. In one embodiment for mixing, after the conveying of step (d), the flow direction is reversed. It is not intended that the present invention be limited by the nature or number of reversals. If the flow direction of said merged microdroplet is reversed even a single time, this process increases the mixing of the reactants.


The present invention contemplates a variety of silicon-based, microdroplet transport channel-containing devices. In one embodiment, the device comprises: i) a housing comprised of silicon, ii) a microdroplet transport channel etched in said silicon, iii) a microdroplet receiving means in liquid communication with a reaction region via said transport channels, and iv) a liquid barrier disposed between said transport channels and a microdroplet flow-directing means. In one embodiment, the device is assembled in two parts. First, the channels are etched in any number of configurations. Secondly, this piece is bonded with a silicon-based chip containing the electronics. This allows for both customization (in the first piece) and standardization (in the second piece).


The present invention also contemplates devices and methods for the sealing of channels with meltable material. In one embodiment, the device comprises a meltable material disposed within a substrate and associated with a heating element.


In one embodiment, the present invention contemplates a method comprising: a) providing a device having a meltable material disposed within a substrate and associated with a heating element; and b) heating said meltable material with said heating element such that said meltable material at least partially liquifies and such that said substrate is not damaged. The method may further comprise c) allowing said liquified meltable material to cool. While the present invention is not limited by the size of the channel, in one embodiment said substrate further comprises a microdroplet channel disposed in said substrate, said meltable material is disposed within said microdroplet channel.


In another embodiment, the present invention contemplates a method for restricting fluid flow in a channel comprising a) providing a device comprising: i) a meltable material disposed within a substrate, said meltable material associated with a heating element; and ii) a diaphragm positioned such that, when extended, it touches said meltable material; b) extending said diaphragm such that it touches said meltable material; and c) heating said meltable material with said heating element such that said meltable material at least partially liquifies and such that said substrate is not damaged. In one embodiment the method further comprises d) allowing said meltable material to cool. While the present invention is not limited by the size of the channel, in one embodiment, the substrate further comprises a microdroplet channel disposed in said substrate, said meltable material disposed within said microdroplet channel.


The present invention also contemplates a method for restricting fluid flow in a channel, comprising: a) providing: i) a main channel connected to a side channel and disposed within a substrate, ii) meltable material disposed within said side channel and associated with a heating element, and iii) a movement means connected to said side channel such that application of said movement means induces said meltable material to flow from said side channel into said main channel; b) heating said meltable material such that said meltable material at least partially liquifies; and c) applying said movement means such that said liquified meltable material flows from said side channel into said main channel. While the present invention is not limited by the movement means, in one embodiment the movement means is forced air. In one embodiment the method further comprises d) allowing said meltable material to cool. While the present invention is not limited by the size of the channel, in one embodiment, the main channel and the side channel are microdroplet channels.


While the present invention is not limited by the nature of the substrate, in one embodiment the substrate comprises silicon or glass. Likewise, the present invention is not limited by the composition of the meltable material. In one embodiment, the meltable material comprises solder. In a preferred embodiment, the solder comprises 40:60 Sn:Pb. In other embodiments, the meltable material is selected from a group consisting of plastic, polymer and wax. Likewise, the present invention is not limited by the placement of the meltable material in the substrate. In another embodiment, the meltable material is placed adjacent to a channel, while in another embodiment it is placed near the junction of more than one channel.


Definitions


The following definitions are provided for the terms used herein:


“Biological reactions” means reactions involving biomolecules such as enzymes (e.g., polymerases, nucleases, etc.) and nucleic acids (both RNA and DNA). Biological samples are those containing biomolecules, such proteins, lipids, nucleic acids. The sample may be from a microorganism (e.g., bacterial culture) or from an animal, including humans (e.g. blood, urine, etc.). Alternatively, the sample may have been subject to purification (e.g. extraction) or other treatment. Biological reactions require some degree of biocompatability with the device. That is to say, the reactions ideally should not be substantially inhibited by the characteristics or nature of the device components.


“Chemical reactions” means reactions involving chemical reactants, such as inorganic compounds.


“Channels” are pathways through a medium (e.g., silicon) that allow for movement of liquids and gasses. Channels thus can connect other components, i.e., keep components “in liquid communication.” “Microdroplet transport channels” are channels configured (in microns) so as to accommodate “microdroplets” While it is not intended that the present invention be limited by precise dimensions of the channels or precise volumes for microdroplets, illustrative ranges for channels and microdroplets are as follows: the channels can be between 0.35 and 50 μm in depth (preferably 20 μm) and between 50 and 1000 μm in width (preferably 500 μm), and the volume of the microdroplets can range (calculated from their lengths) between approximately one (1) and (100) nanoliters (more typically between ten and fifty).


“Conveying” means “causing to be moved through” as in the case where a microdroplet is conveyed through a transport channel to a particular point, such as a reaction region. Conveying can be accomplished via flow-directing means.


“Flow-directing means” is any means by which movement of a microdroplet in a particular direction is achieved. A preferred directing means employs a surface-tension-gradient mechanism in which discrete droplets are differentially heated and propelled through etched channels.


“Hydrophilicity-enhancing compounds” are those compounds or preparations that enhance the hydrophilicity of a component, such as the hydrophilicity of a transport channel. The definition is functional, rather than structural. For example, Rain-X™ anti-fog is a commercially available reagent containing glycols and siloxanes in ethyl alcohol. However, the fact that it renders a glass or silicon surface more hydrophilic is more important than the reagent's particular formula.


“Initiating a reaction” means causing a reaction to take place. Reactions can be initiated by any means (e.g., heat, wavelengths of light, addition of a catalyst, etc.)


“Liquid barrier” or “moisture barrier” is any structure or treatment process on existing structures that prevents short circuits and/or damage to electronic elements (e.g., prevents the destruction of the aluminum heating elements). In one embodiment of the present invention, the liquid barrier comprises a first silicon oxide layer, a silicon nitride layer, and a second silicon oxide layer.


“Merging” is distinct from “mixing.” When a first and second microdroplet is merged to create a merged microdroplet, the liquid may or may not be mixed. Moreover, the degree of mixing in a merged microdroplet can be enhanced by a variety of techniques contemplated by the present invention, including by not limited to reversing the flow direction of the merged microdroplet.


“Nucleic Acid Amplification” involves increasing the concentration of nucleic acid, and in particular, the concentration of a particular piece of nucleic acid. A preferred technique is known as the “polymerase chain reaction.” Mullis et al., U.S. Pat. Nos. 4,683,195 and 4,683,202, hereby incorporated by reference, describe a method for increasing the concentration of a segment of target sequence in a mixture of genomic DNA without cloning or purification. This process for amplifying the target sequence consists of introducing a molar excess of two oligonucleotide primers to the DNA mixture containing the desired target sequence. The two primers are complementary to their respective strands of the double-stranded sequence. The mixture is denatured and then allowed to hybridize. Following hybridization, the primers are extended with polymerase so as to form complementary strands. The steps of denaturation, hybridization, and polymerase extension can be repeated as often as needed to obtain are relatively high concentration of a segment of the desired target sequence. The length of the segment of the desired target sequence is determined by the relative positions of the primers with respect to each other, and therefore, this length is a controllable parameter. By virtue of the repeating aspect of the process, the method is referred to by the inventors as the “Polymerase Chain Reaction” (hereinafter PCR). Because the desired segment of the target sequence become the dominant sequences (in terms of concentration) in the mixture, they are said to be “PCR-amplified.”


“Substrate” as used herein refers to a material capable of containing channels and microdroplet transport channels. Examples include, but are not limited to, silicon and glass.


“Meltable material” as used herein refers to a material that is at least semi-solid (and preferably completely solid) at ambient temperature, will liquify when heated to temperatures above ambient temperature, and will at least partially resolidify when cooled. Preferably, meltable material at least partially liquifies at a temperature such that the substrate is undamaged. That is to say, at the temperature the meltable material liquifies, the substrate and other metals in the substrate does not liquify (readily tested as set forth in Example 6) and does not change its properties. By “changing properties” it is meant that the substrate or metal maintains it structural integrity, does not change its conductivity and does not liquify. Thus, the characteristic of being meltable is not necessarily associated with a particular melting point. Examples include, but are not limited to, solder, wax, polymer and plastic.


“Solder” as used herein refers to a metal or alloy that is a meltable material. Preferably, the solder is a lower temperature solder, such as set forth in U.S. Pat. No. 4,967,950, herein incorporated by reference. “Lower temperature solder” means a eutectic alloy. While the present invention is not limited to a specific solder, one preferred solder composition for the paste is a 63:37 eutectic alloy of tin:lead. Another compatible solder is a 90% metal composition having a 63:35:2 eutectic alloy of tin:lead:silver. Other desired solder compositions such as eutectic Pb:Sn, Pb:In, Pb:In:Sn etc.


“Heating element” as used herein refers to an element that is capable of at least partially liquify a meltable material. A meltable material is “associated with” a heating element when it is in proximity to the heating element such that the heating element can at least partially melt the meltable material. The proximity necessary will depend on the melting characteristics of the meltable material as well as the heating capacity of the heating element. The heating element may or may not be encompassed within the same substrate as the meltable material.


“Diaphragm” as used herein refers to an element capable of being manipulated such that it can at least partially block the passage of fluid in a channel in one position (extended) and permit the flow of fluid in a channel in another position. An “actuating force” is a force that is capable of extending a diaphragm. A “valve seat” is an element designed to accept a portion of the diaphragm when extended. A “movement means” is a means capable of moving liquified meltable material (e.g., force air, magnetic field, etc.).





DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic of an integrated analysis system of the present invention.



FIG. 2 shows a two-part approach to construction of a silicon device of the present invention.



FIG. 3 is a schematic showing the principle of thermally-induced liquid microdroplet motion in a closed channel.



FIG. 4A shows a selected frame of a videotape wherein two microdroplets are at their starting locations in the branches of the Y-channel.



FIG. 4B shows movement by heating the left interface of both microdroplets.



FIG. 4C shows the microdroplets at the intersection.



FIG. 4D shows the merging of the microdroplets to form the combined microdroplet. The open arrowheads in the figure indicate the rear meniscus and the filled arrowheads the leading meniscus for each microdroplet.



FIG. 5A is a photomicrograph of inlay-process heater elements on the surface of a silicon wafer.



FIG. 5B is a scanning electron micrograph (SEM) of an inlay-process heater wire in cross section (the arrows indicate the deposited aluminum, silicon dioxide, and silicon nitride layers).



FIG. 5C is a SEM of a channel formed on glass using a wet-etch process, shown in cross section with the etched face of the wafer immediately adjacent to the intersection of two channels.



FIG. 6A is a photomicrograph of polyacrylamide gel electrophoresis in a wide etched-glass channel.



FIG. 6B is a photomicrograph of a set of four doped-diffusion diode radiation detector elements fabricated on a silicon wafer.



FIG. 6C is an oscilloscope trace of output from the radiation detector showing individual decay events from 32P-labeled DNA.



FIG. 7 is a photo of gel electrophoresis of PCR reactions wherein potentially inhibiting components were added directly to the PCR.



FIG. 8 is one embodiment of a test device for the present invention.



FIG. 9 is a schematic of one embodiment for manufacturing a sealable valve of the present invention.



FIG. 10 is a schematic of one embodiment for the layout of the movable sealing means of the present invention.





DESCRIPTION OF THE INVENTION

The present invention relates to microfabrication and biological reactions in microfabricated devices, and in particular, movement and mixing of biological samples in microdroplets through microchannels. The description of the invention involves I) design of microscale devices (comprising microdroplet transport channels, reaction chambers, electrophoresis ports, and radiation detectors) using silicon and glass substrates, II) movement of discrete microdroplets using a surface-tension-gradient mechanism in which discrete microdroplets are differentially heated and propelled through etched channels, and III) mixing of biological samples for reactions.


I. Design of MicroScale Devices


Although there are many formats, materials, and size scales for constructing integrated fluidic systems, the present invention contemplates silicon microfabricated devices as a cost-effective solution. Silicon is the material used for the construction of computing microprocessors and its fabrication technologies have developed at an unprecedented pace over the past 30 years. While this technology was initially applied to making microelectronic devices, the same techniques are currently being used for micromechanical systems.


Continuous flow liquid transport has been described using a microfluidic device developed with silicon. See J. Pfahler et al., Sensors and Actuators, A21-A23 (1990), pp. 431-434. Pumps have also been described, using external forces to create flow, based on micromachining of silicon. See H. T. G. Van Lintel et al., Sensors and Actuators 15:153-167 (1988). By contrast, the present invention employs discrete droplet transport in silicon (i.e., in contrast to continuous flow) using internal forces (i.e., in contrast to the use of external forces created by pumps).


As a mechanical building material, silicon has well-known fabrication characteristics. The economic attraction of silicon devices is that their associated micromachining technologies are, essentially, photographic reproduction techniques. In these processes, transparent templates or masks containing opaque designs are used to photodefine objects on the surface of the silicon substrate. The patterns on the templates are generated with computer-aided design programs and can delineate structures with line-widths of less than one micron. Once a template is generated, it can be used almost indefinitely to produce identical replicate structures. Consequently, even extremely complex micromachines can be reproduced in mass quantities and at low incremental unit cost—provided that all of the components are compatible with the silicon micromachining process. While other substrates, such as glass or quartz, can use photolithographic methods to construct microfabricated analysis devices, only silicon gives the added advantage of allowing a large variety of electronic components to be fabricated within the same structure.


In one embodiment, the present invention contemplates silicon micromachined components in an integrated analysis system, including the elements identified schematically in FIG. 1. In this proposed format, sample and reagent are injected into the device through entry ports (A) and they are transported as discrete droplets through channels (B) to a reaction chamber, such as a thermally controlled reactor where mixing and reactions (e.g., restriction enzyme digestion or nucleic acid amplification) occur (C). The biochemical products are then moved by the same method to an electrophoresis module (D) where migration data is collected by a detector (E) and transmitted to a recording instrument (not shown). Importantly, the fluidic and electronic components are designed to be fully compatible in function and construction with the biological reactions and reagents.


In silicon micromachining, a simple technique to form closed channels involves etching an open trough on the surface of a substrate and then bonding a second, unetched substrate over the open channel. There are a wide variety of isotropic and anisotropic etch reagents, either liquid or gaseous, that can produce channels with well-defined side walls and uniform etch depths. Since the paths of the channels are defined by the photo-process mask, the complexity of channel patterns on the device is virtually unlimited. Controlled etching can also produce sample entry holes that pass completely through the substrate, resulting in entry ports on the outside surface of the device connected to channel structures.



FIG. 2 shows a two-part approach to construction. Microchannels (100) are made in the silicon substrate (200) and the structure is bonded to a glass substrate (300). The two-part channel construction technique requires alignment and bonding processes but is amenable to a variety of substrates and channel profiles. In other words, for manufacturing purposes, the two-part approach allows for customizing one piece (i.e., the silicon with channels and reaction formats) and bonding with a standardized (non-customized) second piece, e.g., containing standard electrical pads (400).


II. Movement of Discrete MicroDroplets


The present invention describes the controlled movement of liquid samples in discrete droplets in silicon. Discrete droplet transport involves a system using enclosed channels or tubes to transport the liquid to the desired locations (FIG. 1, B). Within the channels, discrete liquid reagent microdroplets can be injected, measured, and moved between the biochemical analysis components. Discrete droplet movement has three advantages. First, each sample droplet is separated from all others so that the risk of contamination is reduced. Second, in a uniform channel, the volume of each sample can be determined by merely measuring the droplet length. Third, the motion of these droplets can be accomplished with simple heating (i.e., using internal forces and no moving parts). Movement is performed using thermal gradients to change the interfacial tension at the front or back of the droplets and, thus, generate pressure differences across the droplet (FIG. 3). For example, a droplet in a hydrophilic channel can be propelled forward by heating the back interface. The local increase in temperature reduces the surface tension on the back surface of the droplet and, therefore, decreases the interfacial pressure difference. The decreased pressure difference corresponds to an increase in the local internal pressure on that end of the droplet (P1 increases). The two droplet interfaces are no longer in equilibrium, with P1 greater than P2, and the pressure difference propels the droplet forward.


That is to say, forward motion can be maintained by continuing to heat the droplet at the rear surface with successive heaters along the channel, while heating the front surface can be used to reverse the motion of the droplet. Applying a voltage to the wire beneath the channel generates heat under the edge of the droplet. Heating the left interface increases the internal pressure on that end of the droplet and forces the entire droplet to the right. The pressure on the interior of the droplet can be calculated knowing the atmospheric pressure, Patm, the surface tension, σ, and the dimensions of the channel. For a circular cross-section, the interior pressure, Pi, is given by Pi=Patm−(4σ cos θ)/d where d is the diameter of the channel and θ is the contact angle. Since σ is a function of temperature (σ=σo(1−bT) where σo and b are positive constants and T is the temperature), increasing the temperature on the left end of the droplet decreases the surface tension and, therefore, increases the internal pressure on that end. The pressure difference between the two ends then pushes the droplet towards the direction of lower pressure (i.e., towards the right). The aqueous droplet shown is in a hydrophilic channel (0<θ<90); for a hydrophobic channel (90<θ<180), heating the right edge would make the droplet move to the right.


Contact angle hysteresis (the contact angle on the advancing edge of the droplet is larger than the contact angle on the retreating edge) requires a minimum temperature difference before movement will occur. The velocity of the droplet after motion begins can be approximated using the equation v=custom characterd2/32 μL where custom character is the pressure difference, μ is the viscosity of the solution, and L is the length of the droplet. The present invention contemplates temperature differences of greater than thirty (30) degrees Centigrade to create movement. Experiments using temperature sensors arrayed along the entire channel indicate that a differential of approximately 40° C. across the droplet is sufficient to provide motion. In these experiments, the channel cross-section was 20 μm×500 μm, and the volume of each of these droplets can be calculated from their lengths and is approximately 100 nanoliters for a 1 cm long droplet.


III. Flow Control with Sealed Valves


The present invention contemplates the use of sealed valves to control fluid flow. While the present invention is not limited to a particular sealing method, in one embodiment, an actuating force pushes a diaphragm against a valve seat to restrict fluid flow and the diaphragm is then sealed to the valve seat. In such an embodiment, the solder pads are associated with a heating element that can melt the solder. This liquified solder flows over areas of the valve seat and diaphragm to cover contamination, cracks and crooks between the diaphragm and valve seat. With the actuating force still holding the diaphragm and valve-seat together, the heating element is turned off to allow the solder to cool and re-solidify. Upon solidification, the actuating force can be released and the valve is sealed. To open the valve again, the solder can be liquified without applying an actuation force.


In a preferred embodiment, the valve is designed such that solder pads are placed on the diaphragm or valve seat. While the present invention is not limited to a precise method of placing these solder pads, it is specifically contemplated that they can be electroplated.


IV. Mixing Biological Samples in Reactions


Droplet motion (described generally above) is contemplated as one step in a pathway. The other steps typically involve sample mixing and a controlled reaction. For example, the integral heaters arrayed along the entire surface of the channel used for droplet motion also allow for a region of a channel to be used as a thermal reaction chamber. For sample mixing prior to the reaction, a Y-channel device is contemplated (FIG. 4A). In such a device, a first droplet containing a first sample (e.g., nucleic acid) is moved along one channel of the Y-channel device, and a second droplet containing a second sample (e.g., a restriction digest enzyme in digestion buffer) is moved along the other channel of the Y-channel device (FIGS. 4B and 4C)


Following sample merging (FIG. 4D), there is the concern that the combined samples have not been properly mixed. That is to say, if two similar microdroplets enter the single channel in laminar flow at the same flow rate, they will form an axially uniform droplet but will not be mixed width-wise. Width-mixing can be accomplished in a number of ways.


First, there is simple diffusion, although, for large DNA molecules, the characteristic time for this mixing could be on the order of several hours or more. Circulation patterns generated inside the droplets during movement and heating significantly reduce this time. In this regard, the present invention contemplates maintaining the mixture as a heated mixture (e.g., maintaining the temperature at 65° C. for 10 minutes) using the integral heaters and temperature sensors.


Second, the present invention contemplates mixing by reversing the flow direction of the mixture over a relatively short distance in the channel. While a variety of reverse flow approaches are possible, one or two direction changes over a distance comprising approximately two droplet lengths has been found to be adequate.


Finally, there is the mixing approach wherein the mixture is moved against or over physical obstacles. For example, the mixture can be either “crashed” back against merge point of the Y-channel or simply moved over deliberate imperfections in the channel (i.e., “roller coaster” mixing).


Successful mixing, of course, can be confirmed by characterization of the product(s) from the reaction. Where product is detected, mixing has been at least partially successful. The present invention contemplates, in one embodiment, using electrophoresis to confirm product formation.


DESCRIPTION OF PREFERRED EMBODIMENTS

The description of the preferred embodiments involves: I) microfabrication techniques for manufacture of silicon-based devices; II) channel treatment for optimum flow and reproducibility; and III) component design (particularly the electrophoresis module and the radiation detectors).


I. Microfabrication of Silicon-Based Devices


As noted previously, silicon has well-known fabrication characteristics and associated photographic reproduction techniques. The principal modern method for fabricating semiconductor integrated circuits is the so-called planar process. The planar process relies on the unique characteristics of silicon and comprises a complex sequence of manufacturing steps involving deposition, oxidation, photolithography, diffusion and/or ion implantation, and metallization, to fabricate a “layered” integrated circuit device in a silicon substrate. See e.g., W. Miller, U.S. Pat. No. 5,091,328, hereby incorporated by reference.


For example, oxidation of a crystalline silicon substrate results in the formation of a layer of silicon dioxide on the substrate surface. Photolithography can then be used to selectively pattern and etch the silicon dioxide layer to expose a portion of the underlying substrate. These openings in the silicon dioxide layer allow for the introduction (“doping”) of ions (“dopant”) into defined areas of the underlying silicon. The silicon dioxide acts as a mask; that is, doping only occurs where there are openings. Careful control of the doping process and of the type of dopant allows for the creation of localized areas of different electrical resistivity in the silicon. The particular placement of acceptor ion-doped (positive free hole, “p”) regions and donor ion-doped (negative free electron, “n”) regions in large part defines the interrelated design of the transistors, resistors, capacitors and other circuit elements on the silicon wafer. Electrical interconnection and contact to the various p or n regions that make up the integrated circuit is made by a deposition of a thin film of conductive material, usually aluminum or polysilicon, thereby finalizing the design of the integrated circuit.


Of course, the particular fabrication process and sequence used will depend on the desired characteristics of the device. Today, one can choose from among a wide variety of devices and circuits to implement a desired digital or analog logic feature.


In a preferred embodiment, channels were prepared on 500 μm thick glass wafers (Dow Corning 7740) using standard aqueous-based etch procedures. The initial glass surface was cleaned and received two layers of electron beam evaporated metal (20 nm chromium followed by 50 nm gold). Photoresist Microposit 1813 (Shipley Co.) was applied 4000 rpm, 30 seconds; patterned using glass mask 1 and developed. The metal layers were etched in chromium etchant (Cr-14, Cyantek Inc.) and gold etchant (Gold Etchant TFA, Transene Co.) until the pattern was clearly visible on the glass surface. The accessible glass was then etched in a solution of hydrofluoric acid and water (1:1, v/v). Etch rates were estimated using test wafers, with the final etch typically giving channel depths of 20 to 30 μm. For each wafer, the depth of the finished channel was determined using a surface profilometer. The final stripping (PRS-2000, J. T. Baker) removed both the remaining photoresist material and the overlying metal.


In one embodiment, channels etched on glass in the above-described manner, were bonded to the heater-element wafer in a two-part construction approach using optical adhesive (SK-9 Lens Bond, Sumers Laboratories, Fort Washington, Pa.). The bond was cured under an ultraviolet light source (365 nm) for 12 to 24 hours.


Initial device design by the present inventors involved single layers of silicon. However, experience showed these to be inadequate to prevent short circuiting due to (necessary) liquid microdroplets within the channels (see experiments described below). The preferred design involves a triple layer of oxides. Such a preferred device capable of moving and mixing nanoliter droplets was constructed by bonding a planar silicon substrate to channels etched in a glass cover. A series of metal heaters was inlaid on the silicon substrate as two parallel lanes merging into a single lane (a “Y”-shape) (FIG. 5A). The heating elements were formed by first coating the wafer with a 1.0 μm layer of thermal silicon dioxide Next, 0.35 μm deep, 5 μm wide grooves were reactive-ion etched (RIE) into the silicon dioxide following the pattern set in an overlying photoresist. Aluminum was deposited (0.35 μm) across the entire wafer using electron beam evaporation and the metal layer was “lifted-off” from all surfaces having intact photoresist using a stripping solution. The metal inlay process gives a relatively planar surface and provides a uniform base for deposition of a solution-impermeable barrier layer. The barrier layer is made by a sequence of three plasma-enhanced chemical vapor depositions (PECVD): 1.0 μm silicon oxide (SiOx), 0.25 μm silicon nitride (SixNy), and 1.0 μm silicon oxide (SiOx) (FIG. 5B). Some heating elements were also used as resistive temperature sensors.


Heater elements were fabricated as follows. Silicon wafer (p-type, 18-22½-cm, custom character100custom character, boron concentration Å 1015 cm−3) was used as a substrate for growth of SiO2 thermal oxide (1 μm); photoresist (AZ-5214-E, Hoescht-Celanese) was applied and spun at 3000 rpm, 30 seconds. The resist was patterned (metal 1) and developed. Reactive ion etch (RIE, PlasmaTherm, Inc.) was performed to 0.35 μm depth into the SiO2 layer at the following conditions: CHF3, 15 sccm (standard cubic centimeters per minute); CF4, 15 sccm; 4 mTorr; DC bias voltage of 200V, 100 W, 20 minutes. The etch depth was measured by profilometer and 0.35 μm metallic aluminum was electron beam deposited. The resist and overlying metal was lifted off by development using Microposit 1112A remover in solution (Shipley Co.). The barrier layers consist of sequentially deposited 1 μm SiOx, 0.25 μm SixNy, and 1 μm SiOx, using plasma-enhanced chemical vapor deposition (PECVD). RIE was used to etch contact holes to the metal layer using a second mask (CHF3, 15 sccm; CF4, 15 sccm; 4 mTorr; and DC bias voltage of 200V, 100 W, 120 minutes).


As shown in FIG. 5, the elements are arrayed as two parallel lanes, each 500 μm wide, merging into one lane. The individual heaters consist of paired aluminum wires (5 μm) winding across the 500 μm wide region. The broad metal areas on either side of the elements are bonding locations for connection to external circuitry. The width of the aluminum element is 5 μm. The channel in FIG. 5C has identical width and design configurations as the heating element lanes in FIG. 5A, and is uniformly etched 500 μm wide and approximately 20 μm deep.


The heating-element wafer was bonded to a glass wafer containing etched channels with the same “Y” format. An aqueous chemical etch of concentrated hydrofluoric acid was used to produce channels with defined side walls and uniform depth. The etched channels are defined by a chromium/gold mask and are 500 μm wide and approximately 20 μm deep (FIG. 3C). The complementary silicon heater and glass channel wafers were aligned and then bonded with adhesive to form the finished device.


Each heating element used as a temperature sensor is preferably first calibrated by measurement of electrical resistance at 22° C. and 65° C. under constant voltage; intermediate temperatures are estimated by linear interpolation.


II. Channel Treatment


Prior to performing microdroplet motion and biological reactions, the channels are preferably treated by washing with base, acid, buffer, water and a hydrophilicity-enhancing compound, followed by a relatively high concentration solution of non-specific protein. In a preferred embodiment, the channels are washed with approximately 100 μl each of the following solutions in series: 0.1N NaOH; 0.1N HCl; 10 mM Tris-HCl (pH 8.0), deionized H2O, Rain-X Anti-Fog (a hydrophilicity-enhancing compound commercially available from Unelko Corp., Scottsdale, Ariz.), and 500 μg/μl bovine serum albumin (non-specific protein commercially available in restriction enzyme grade from GIBCO-BRL). The wafer was placed on a stereoscope stage (Olympus SZ1145), and the contact pads for the heating elements were connected to a regulated power supply. Heating occurred by passing approximately 30 volts through the element in short pulses and observing the movement rate of the droplets. A detectable reduction in droplet volume from evaporation was noted in each experiment, usually of less than 30%. Droplet movement was recorded with a Hamamatsu video camera on videotape.


III. Component Design


The present invention contemplates one or more gel electrophoresis modules as a component of the microscale device. Theoretical and empirical research has indicated that reducing the thickness of the electrophoresis channel leads to improved resolution. Thinner gels dissipate heat more readily and allow higher voltages to be used, with concomitant improvements in separation. The position and width of the electrophoresis detector are also critical to the ultimate resolution of the electrophoresis system. A micromachined electronic detector, such as a photodiode, placed in the underlying silicon substrate can be less than one micron from the gel matrix and can have a width of 5 microns or less. Since the gel length required for the resolution of two migrating bands is proportional to the resolution of the detector, the incorporation of micron-width electronic detectors can reduce the total gel length required for standard genotyping by at least an order of magnitude.


To demonstrate that standard gel electrophoresis can operate in micron-diameter channels, modules were fabricated using etched glass channels identical to FIG. 4B and fluorescent-labeled DNA (YOYO intercalating dye). Polyacrylamide gel electrophoresis of a complex DNA mixture is shown in FIG. 6A in a channel 500 μm wide and 20 μm deep. The electrophoresis was performed with the positive electrode to the right and the DNA sample applied at the left. The white vertical line is the gel-to-buffer interface. The DNA sample (BluescriptKS digested with MspI) is labeled with intercalating UV-fluorescent dye (YOYO-1) and is visualized under incandescent light. Separation of the component bands is clearly visible less than 300 μm from the buffer reservoir-to-gel interface. The high resolution of the detector (in this case, a microscope) allowed the use of an unusually short gel, resolving several closely eluting bands.


The present invention contemplates an electrophoresis unit that integrates a micromachined channel and an electronic DNA detector. The channel is constructed using a sacrificial etch process on a single silicon wafer rather than the bonded surface-etch method described earlier. In the sacrificial etch technique, the channel configuration is patterned by depositing on the wafer surface an etch-sensitive material (phosphosilicate glass, SiO2.Px) with a thickness equivalent to the desired channel height. A triple-layer overlay of plasma-enhanced chemical vapor deposited silicon nitride, undoped polycrystalline silicon, and silicon nitride (SixNy/polySi/SixNy) completely covers the sacrificial material with the exception of small access holes on the top or sides. A selective liquid etch removes the sacrificial layer material, but not the overlay or the underlying substrate. The sacrificial etch technique results in a complete channel being formed directly on the substrate containing the electronic components (FIGS. 4C and 4D). The 3 μm deep channel has two buffer reservoirs on either end with integral phosphorus-doped polycrystalline silicon electrodes. The channel height formed by this technique (˜3 μm) is considerably smaller than the height of the bonded structures due to the limitations of the sacrificial layer deposition and the strength of the overlying layer. Note that, for these channel dimensions, liquid drops would have volumes on the order of picoliters.



FIG. 6B is photomicrograph of a set of four doped-diffusion diode radiation detector elements fabricated on a silicon wafer. For each element, the three parallel dark lines define the diffusion regions of the central the detector flanked by the guard ring shielding electrodes. The diffusion regions are approximately 300 μm long and 4 μm wide.


A radiation detector, consisting of a 10 μm wide “p-n”-type diode with a 5 μm wide guard ring around the outer edge, is fashioned directly into the silicon substrate underneath the channel. In this implementation, an integral radiation detector was chosen because of (i) high sensitivity (a single decay event), (ii) small aperture dimensions, and (iii) well-know fabrication and response characteristics. On this electrophoresis system, a 1 cm long, 3 μm thick gel is able to perform as separation on a 80 and a 300 base-pair fragment of DNA. It should be noted that this diode, although currently configured for high-energy beta particle detection, can also operate as a photon detector. With proper wavelength filters and light sources, detection of fluorescence emission may be accommodated with a similar device.


Radiation detectors were prepared as follows. A 200½-cm, custom character100custom character, float zone, boron-doped, p-type silicon wafer was used as a substrate. Diffused layers of phosphorus (5×1014 cm−2) and boron (1×1015 cm−2) were ion-implanted onto the sample in lithographically-defined regions; thermal silicon oxide was grown (0.2 μm at 900° C.) over the wafer; and contact holes were etched to the diffusion layer using buffered hydrofluoric acid solution (5:1). A 3.3 μm layer of Microposit 1400-37 photoresist was patterned to define the metal pads; 50 nm chromium followed by 400 nm gold was evaporated over the resist; and the metallization lifted off the regions retaining the resist. A layer of Microposit 1813 photoresist was applied across the wafer and baked for 110° C. for 30 minutes to form an aqueous solution barrier. Radioactive phosphorus (32P) decay events could be detected using a sample of labeled DNA in PCR reaction buffer placed on the photoresist layer. The detector was connected to a charge-sensitive preamplifier (EV-Products 550A), followed by a linear shaping amplifier and a standard oscilloscope.



FIG. 6C shows an oscilloscope trace of output from the radiation detector showing individual decay events from 32P-labeled DNA. The aqueous DNA sample was placed directly on the detector and sampled for 30 seconds. The screen is displaying a vertical scale of 0.5V/division and horizontal scale of 20 μsec/division.


Experimental


The following examples serve to illustrate certain preferred embodiments and aspects of the present invention and are not to be construed as limiting the scope thereof.


In the experimental disclosure which follows, the following abbreviations apply: eq (equivalents); M (Molar); μM (micromolar); N (Normal); mol (moles); mmol (millimoles); μmol (micromoles); nmol (nanomoles); gm (grams); mg (milligrams); μg (micrograms); L (liters); ml (milliliters); μl (microliters); cm (centimeters); mm (millimeters); μm (micrometers); nm (nanometers); ° C. (degrees Centigrade); Ci (Curies); MW (molecular weight); OD (optical density); EDTA (ethylenediamine-tetracetic acid); PAGE (polyacrylamide gel electrophoresis); UV (ultraviolet); V (volts); W (watts); mA (milliamps); bp (base pair); CPM (counts per minute).


EXAMPLE 1

This example describes approaches to the problem of forming a moisture barrier over electrical elements of the microscale device. Initial prototypes employed 5000 angstroms of aluminum and covered it with PECVD SiOx. Upon testing, it was determined that the liquids were penetrating this later and destroying the aluminum heating elements.


Without clear evidence what was causing this problem, it was hypothesized that the step height of the aluminum was causing cracks in the passivation layer (the oxide). In order to alleviate the cracking problem, a layer of SixNy was tried between two layers of SiOx, with the thought that the additional thickness would overcome the cracking caused by the step height. It did not.


As a follow-up approach, a thinner layer (500 angstroms) of aluminum was tried. This gave 1/10th the step height of the original prototype devices. On top of this aluminum, a triple layer of SiOx, SixNy, and SiOx was employed. Moreover, the process for making the SixNy layer was changed to one which would give a more dense layer. This appeared to solve the problem. However, the thinner layer of aluminum created a higher resistance which was not acceptable. It was determined that one needed a way to generate thicker layers of aluminum for lower resistance, yet keep the surface relatively smooth (planar). An etch back process was used (now called “the inlay process”) to accomplish the task. By etching back into a layer of SiOx depositing aluminum in the resulting cavity, then stripping the resist mask, a surface was obtained with a step height low enough to prevent cracking of the passivation layers.


It was also discovered that the metal bonding pads were not adhering well to the initial PECVD SiOx layer. To overcome the problem, the process was modified by using a wet thermal SiO2 layer.


EXAMPLE 2

This example describes approaches to enhancing droplet motion by surface treatment. In this regard, the principle of using surface tension to cause droplets to move may be applied to either hydrophilic or hydrophobic surfaces. Glass, for instance, is naturally hydrophilic with a near zero contact angle with water. Because the oxide coating of the present invention is made principally of the same material as glass, it was expected that the devices would also exhibit near zero angles. It was discovered, however, that the actual construction materials had contact angles far from zero, thus enhancing the effects of contact angle hysteresis (discussed in greater detail in Example 3). For instance, water gave a contact angle (static) of ˜42° on polyamide, ˜41° on SiO2 (major component of most glasses), ˜62° on silicone spray. To enhance the surface effectiveness, several treatment processes for both hydrophilic and hydrophobic surfaces were tried, as described below.


To improve the hydrophilicity of a surface, several cleaning procedures were tried. It has been reported that surface contamination and/or roughness can reduce the hydrophilicity of surfaces. Therefore, a high concentration chromic acid cleaning, a high concentration sulfuric acid cleaning, a baking procedure (to 600° C. for 8 hrs. to burn off contaminates), and surface coatings were tried. The acid cleaning procedures were not as effective as the baking procedure; however, neither proved to be compatible with the devices since the concentrated acids would attack the aluminum pads and the high temperature could peal the aluminum (melting pt. ˜660° C.) or break the adhesive bond between the heater chip and the channel.


Rain-X antifog (commercially available) as a treatment was observed to work. This is a surface treatment which makes surfaces hydrophilic. Although, the resulting surfaces may not be 0°, by using this coating the entire surface gets treated giving a uniform surface for the droplet. Experimentally, it was found that Rain-X antifog treatments greatly enhanced droplet motion experiments using heat. Another such treatment which was tested but which did not work was a material called SilWet. This material is used in the agriculture industry for enhancing the wetting of plants with agricultural sprays.


To obtain hydrophobic surfaces, the present inventors tried coating capillaries with Rain-X and silane treatments. Neither of these gave angles much greater than 90°, therefore, would not work with this mechanism. These treatments would have to have given angles ˜180° to be useful for hydrophobic studies of motion. Eventually, it was discovered that one could apply a teflon coating that was sufficiently hydrophobic to possibly warrant future tests.


EXAMPLE 3

This example describes approaches to droplet motion by heat treatment. As noted previously (above), the contact angle on the advancing end of a liquid droplet in motion (known as the advancing contact angle) is greater that the that on the receding end (receding contact angle). In the case of a hydrophilic surface—such as water on glass—this tends to create a back pressure countering attempts at forward motion by heating the back side of a droplet. This is best shown by a simple model describing laminar flow through a channel.


Average Flow Through a Circular Channel:

<v>=−ΔP*[R2/(8 μL]

where: Δ=value at back−value at front end of droplet

    • ΔP=(1/R)*(ΔG)=pressure difference between droplet ends
    • ΔG=change in surface tension between the ends of the droplet.
    • R=channel radius
    • L=droplet length
    • μ=viscosity


      Also, for water, ΔG=−constant*ΔT, where temperature increases lower the surface tension of most liquids (constant=0.16 dyn/cm for water).


Therefore:

<v>=−(ΔG)*(1/R)*[R2/(8 μL)]=[−0.16*ΔT*R/(8 μL)]

  • where: ΔT=Tback−Tfront
    giving: <v>=[0.16*R/(8 μL)]*(Tback−Tfront).

    This expression indicates that any heating on the back end of the droplet (if the front remains at a lower temperature) will cause the liquid droplet to move. This was not the case experimentally, however. By way of studies using glass capillaries, it was found that there was a minimum temperature difference required to move the droplet. This effect is believed to be the result of contact angle hysteresis (CAH). In CAH, the advancing contact angle is greater than the receding contact angle resulting in a sort of back pressure which must be overcome to achieve droplet movement. CAH occurs when the interface is placed in motion (dynamic angles). To account for this effect, it was included in a steady-state (1D) model for flow. For instance, if the advancing angle is 36° and the receding angle is 29° (with the front of the droplet being 25° C.), then the back of the droplet would need to be heated to ˜60° C. for a 1 mm long droplet in a 20 μm high channel. This is just one example situation.


It was discovered experimentally, however, that the channel dimension and fluid parameters (other than surface tension) do not affect whether or not the droplet will move. They do determine the magnitude of motion (if it occurs). What does determine whether motion will occur or not is the following inequality:

Gfront/Gback>(Rfront/Rback)*(cos βback/cos βfront)

  • where: β=contact angle.


The present calculations suggest that a ˜35° C. difference between the front and back of a droplet should be sufficient to initiate droplet motion in a system with advancing angles of 36° and receding angles of 29° in a 20 μm high channel. Experimental testing of actual devices however, showed that the front of the droplet heats relatively quickly thus reducing the temperature difference needed for movement between the front and the back of the droplet. This effect required us to use higher voltages to obtain droplet motion. Voltages typically in the range of ˜30° Volts were found to be required to obtain motion. Further experiments showed that the resulting temperature difference was ˜40° C. between the front and back of the droplet thus corroborating the initial determination of the requirements.


Discrete droplet motion in a micromachined channel structure using thermal gradients is demonstrated in the videorecorded images of FIG. 4. The device consists of a series of aluminum heaters inlaid on a planar silicon dioxide substrate (similar to the structure shown in FIG. 2) and bonded by glue to a wet-etched glass channel (20 μm depth, 500 μm width). Liquid samples were manually loaded into the two channels on the left using a micropipette. Heating the left interface of each droplet propels it toward the intersection of the channels. At the intersection, the droplets meet and join to form a single larger droplet. Note that, since the channel cross-section is 20 μm×500 μm, the volume of each of these droplets can be calculated from their lengths and is approximately 50 nanoliters.


The heaters along the entire surface of the channel shown in FIG. 4 allow it to be used as a thermal reaction chamber in addition to a droplet-motion device. The upper droplet in the figure contains a DNA sample, while the lower contains a restriction digest enzyme (TaqI) and digestion buffer. Following sample merging, the combined droplet was maintained at 65° C. for 30 minutes using the integral heaters and temperature sensors. The completed enzymatic reaction was confirmed by expressing the droplet from the right end of the channel and loading it onto a capillary gel electrophoresis system with a laser-induced fluorescence detector. The chromatogram produced by the silicon-device sample was similar to chromatograms generated from DNA digests runs in a standard polypropylene microreaction vessel (not shown).


EXAMPLE 4

This example describes various approaches for bonding channels to the substrate which contains circuitry for heating and temperature sensing of the device of the present invention (see discussion of two-part construction, above). First attempts involved Polyamide; regular polyamide was unsatisfactory in that it was found the two pieces would not stick together.


Follow-up attempts involved a photo-definable Polyamide. This produced a sticky surface, but would not give a perfect seal along the channel. It was discovered that the solvents released during the final baking process were causing pockets in the polyamide layer. An adhesion layer was needed which would seal by ‘curing’ and not release solvents.


Several different epoxies and glues were investigated, as listed below.
















Adhesive
Form
Dries
Texture
Comments




















1.
Dymax UV Glue
Gel
Clear
Rubbery
Cures on UV exposure.


2.
Carter's Rubber
Goo
Yellow/Clear
Rubbery
Dries quickly and



Cement



stringy when thinned.


3.
Borden's Krazy
Liquid
Clear
Hard
Thin, dries on first



Glue



contact.


4.
UHU Bond-All
Gel/Goo
Clear
Hard
Dries quickly and







stringy when thin.


5.
Dennison
Paste
Clear
Hard
Will not flow on



Permanent Glue



applying.



Stick






6.
Elmer's Glue-All
Thick Liquid
White
Hard
Slow drying.



(Borden)






7.
Liquid Nails
Thin Paste
Wood-like
Hard
Thick, dries quickly







when thinned


8.
Devcon 5-Minute
Gel
Yellow/Clear
Hard
Thick, cures on about



Epoxy



5 min.


9.
Scotch Double-
Tape
Clear
Rubbery
Tape.



Stick Tape






10.
Dow Corning
Thick Gel
Frosty
Soft
Seals but does not bond.



High Vacuum







Grease






11.
Nujol Mineral
Liquid
Clear
Runny
Neither seals (doesn't



Oil (Perkin



spread on glass) nor bonds.



Elmer)






12.
Household Goop
Gel/Goo
Clear
Rubbery
Contact cement which







dries stringy.


13.
Permatex
Gel/Goo
Yellow/Clear
Rubbery
Dries quickly and



Weather Strip



stringy when thinned.



Cement






14.
Thick Gel Super
Gel
Clear
Hard
Does not cure on



Glue



contact but does







quickly.


15.
DAP Weldwood
Goo
Orange/Clear
Rubbery
Contact cement which



Contact Cement



gets stringy when







thinned.


16.
Scotch (3M)
Thin Goo
Yellow/Clear
Rubbery
Spray. ‘Gooey’ but



Photo Mount



not stringy.



Spray Adhesive






17.
Silicone Resin
Liquid
Clear
Smooth
Spray. Dries to thin,



(spray) Lacquer



clear, and sealed



(GC Electronics)



coating.









A preferred glue was a UV cured glue, although the process of applying the UV glue is tedious and requires some practice to avoid putting the glue in places where it does not belong, e.g., in the channels.


Hydroxide bonding and screen printing of bonding substances was also attempted. Another option was glass tape, but the high temperatures required to melt the tape appeared to be too high for the present devices.


EXAMPLE 5

This example describes a nucleic acid amplification reaction on a silicon-based substrate. The established DNA biochemistry steps for PCR occur within physiological conditions of ionic strength, temperature, and pH. Thus, the reaction chamber components have design limitations in that there must be compatibility with the DNA, enzymes and other reagents in solution.


To assess biocompatability, components were added to a standard PCR reaction. The results (see FIG. 7) indicated that crystalline silicon may not be the ideal material for biological compatibility. Given these results, it may be desirable to modify the surface of the micromachined silicon substrate with adsorbed surface agents, covalently bonded polymers, or a deposited silicon oxide layer.


To form a biologically compatible heating element, the present inventors began by coating a standard silicon wafer with a 0.5 μm layer of silicon dioxide. Next, a 0.3 μm deep, 500 μm wide channel was etched into the silicon oxide and gold or aluminum was deposited (0.3 μm thick). This inlay process results in a relatively planar surface (FIG. 2A) and provides a base for deposition of a water-impermeable layer. The impermeable layer is made by a sequence of three plasma enhanced vapor depositions: silicon oxide (SiOx), silicon nitride (SixNy), and silicon oxide (SiOx). Since the materials are deposited from the vapor phase the precise stoichiometries are not known. A thin metal heater design was used for this device rather than the doped-silicon resistive heaters previously demonstrated for micromachined PCR reaction chambers, since the narrow metal inlay allows viewing of the liquid sample through a transparent underlying substrate, such as glass or quartz. Also, the use of several independent heating elements permits a small number to operate as highly accurate resistive temperature sensors, while the majority of elements are functioning as heaters.


A device fabricated with metal resistive heaters and oxide/nitride/oxide coating was tested for biological compatibility and temperature control by using PCR amplification of a known DNA template sample. The reaction was carried out on the planar device using twenty microliters of PCR reaction mix covered with mineral oil to prevent evaporation. The reaction mixture was cycled through a standard 35-cycle PCR temperature cycling regime using the integral temperature sensors linked to a programmable controller. Since the reaction volume was significantly larger than intended for the original heater design, a polypropylene ring was cemented to the heater surface to serve as a sample containment chamber. In all test cases, the presence of amplified reaction products indicated that the silicon dioxide surface and the heater design did not inhibit the reaction. Parallel amplification experiments performed on a commercial PCR thermocycler gave similar results. A series of PCR compatibility tests indicated that the reaction on the device is very sensitive to controller settings and to the final surface material in contact with the sample (not shown).


From the above it should be evident that the present invention can be adapted for high-volume projects, such as genotyping. The microdroplet transport avoids the current inefficiencies in liquid handling and mixing of reagents. Moreover, the devices are not limited by the nature of the reactions, including biological reactions.


EXAMPLE 6

In this example, a test structure is fabricated (FIG. 8). The test structure is very simple (FIG. 8). The main part is constructed from a two mask process with five layers of materials on top of the Si substrate. Proceeding from the lowest to the uppermost layer, the SiO2 serves as an insulator between the Si substrate and the other metal layers, which function as solder pads and heating elements. The Ti layer (250 A) is for adhesion of Ni. The layers of Ni (1000 A) and Au (1000 A) act as a diffusion barrier for the solder. The Au layer also serves as a wettable pad. Finally, the layer of solder is for bonding two substrates together. The solder will melt by heating the metal layers. Another substrate that will be bonded has the same construction except for the solder.


A thermo-pneumatic microvalve is utilized in the test structure. The schematic and process flow of the microvalve is shown in FIG. 9. A corrugated diaphragm is chosen for its larger deflection and higher sensitivity. The diaphragm (side length=1000 um, thickness=3 um, boss size length=500 um boss thickness=10 um) has a deflection of 27 um at an applied pressure of 1 atm. This applied pressure is generated by a thermo-pneumatic mechanism, which provides a greater actuation force. A pressure of 1 atm is generated in the cavity between the diaphragm and glass by Freon-11 when it is heated 11° C. above room temperature. As set forth in FIG. 9, ten masks are anticipated to fabricate the microvalve.



FIG. 9
a shows a portion of a silicon substrate 10, which is a p-type (100)-oriented Si wafer of normal thickness and moderate doping (>1 cm). The preferred wafer thickness, however, is ordinarily a function of the wafer diameter. The upper surface 12 of the silicon wafer containing substrate 10 is lapped, polished and cleaned in the normal and accepted manner. Isotropic etching using reactive ion etching (RIE) forms the diaphragm corrugations 14 with photoresist as the masking material.



FIG. 9
b shows the definition of deep boron diffusion areas 16 to form the rims, center bosses, inlet and outlet holes of the finished device. FIG. 9c shows the deposition of shallow boron diffusion areas 18 to form a diaphragm. The various metal layers, including solder 20, are then deposited. The deep and shallow boron diffusion processes define the shape of the diaphragm and the etch-stop for the dissolved wafer process.


Following this, FIG. 9d shows the definition of oxide layer 22 to serve as insulator of the solder of the finished device. Ti adhesion/Ni/Au barrier and wettable pads 24 are then deposited as shown in FIG. 9e. The solder mold 26 of Ni and photoresist is then defined as shown in FIG. 9f) and the first Ni channel 28 is created by surface-micromachined using photoresist as sacrificial layers. The Ni channel hole is defined using EDP to remove the sacrificial layers, and define an channel hole 30 (FIG. 9g).


A second Ni channel 32 is defined by Ni and photoresist as set forth in FIG. 9h, and inlet 34 and outlet 36 holes are defined using EDP to remove the sacrificial layers (FIG. 9i).


Lastly, a Ti/Pt heater in glass 38 is anodically bonded to the silicon substrate (FIG. 9j). Freon-11 fills the cavity through a hole (not shown) in the glass substrate. This hole is created from a diamond drill bit and sealed with epoxy.


EXAMPLE 7

In this example, a low melting point solder was intended to be utilized in the test structure. Because a universally useful solder-sealed microvalve will be used in a gas phase microanalytical system, it is not desirable to use a high melting point (m.p.) solder (>200° C.), which might affect the gas properties. In addition, a high m.p. solder may affect other components on the device, such as integrated circuits, and increase power consumption. As a result, low melting point solder is required. Bismuth-bearing solders have the lowest m.p.'s of 47-138° C. However, when a test structure was dipped into a pool of solder belonging to this group, all the metal layers dissolved into the solution of solder. Moreover, this solder was not selective in wetting the surface of the test structure.


EXAMPLE 8

In light of the results of the experiment set forth in Example 7, an attempt was made with commonly available 60:40 Sn:Pb solder (m.p. 183° C.). When the test structure was dipped into a solution of this solder, the metal layers remained intact. Furthermore, these layers demonstrated excellent wettability for the solder, i.e. the solder was confined only to the areas of metals.


EXAMPLE 9

In this example, a device and method for blocking fluid flow in a channel is described. FIG. 10 sets forth a test schematic for these embodiments. 60:40 Sn:Pb solder 40, associated with a heating element 42, is placed within a side channel 44. The heating element 42 at least partially liquifies the solder 40 and air flow 46 moves the liquified solder from the side channel into a main channel 48 and cooled, blocking the main channel.

Claims
  • 1. A method, comprising: a) providing a channel defined within a generally planar substrate and having a liquid barrier, said barrier comprising a first silicon oxide layer, a silicon nitride layer, and a second silicon oxide layer, wherein said channel allows for movement of at least one liquid;b) heating a mass of meltable material disposed adjacent to said channel within said substrate; andc) moving said heated mass of meltable material into said channel, wherein said mass of meltable material is at least partially liquified.
  • 2. The method of claim 1, wherein heating said mass of meltable material comprises a resistive element in thermal contact with said generally planar substrate.
  • 3. The method of claim 2, wherein said resistive element is integral with said generally planar substrate.
  • 4. The method of claim 1, wherein said at least one liquid is at least one discrete microdroplet having a volume of about 100 nanoliters or less.
  • 5. The method of claim 1, wherein said channel has a cross-section of about 20 μm×500 μm.
  • 6. The method of claim 1, wherein said mass of meltable material comprises a material selected from the group consisting of wax, solder, polymer and plastic.
  • 7. The method of claim 1, wherein said at least one liquid is moved along said channel into a reaction region, wherein said reaction region comprises an integral heater.
  • 8. The method of claim 4, wherein said method further comprises merging a first discrete microdroplet with a second discrete microdroplet under conditions that said merged microdroplets are maintained as a heated mixture.
  • 9. The method of claim 8, wherein said first liquid comprises a nucleic acid and said second liquid comprises a nuclease.
  • 10. A method, comprising: a) merging a first liquid and a second liquid within a channel defined within a generally planar substrate, said channel comprising a liquid barrier, wherein said barrier comprises a first silicon oxide layer, a silicon nitride layer, and a second silicon oxide layer;b) heating a mass of meltable material disposed adjacent to said channel within said substrate; andc) moving said heated mass of meltable material into said channel, wherein said mass of meltable material is at least partially liquified.
  • 11. The method of claim 10, wherein said first liquid comprises a nucleic acid and said second liquid comprises a nuclease.
  • 12. The method of claim 11, wherein said first liquid is a first discrete microdroplet and said second liquid is a second discrete microdroplet.
  • 13. The method of claim 11, further comprising maintaining said first and second liquid as a heated mixture.
Parent Case Info

This is a Divisional of application Ser. No. 11/119,539 filed on Apr. 29, 2005 now U.S. Pat. No. 8,071,056, which is a Continuation of application(s) Ser. No. 09/517,680 filed on Mar. 2, 2000, now U.S. Pat. No. 6,949,385, issued Sep. 27, 2005, which is a Continuation of U.S. patent application Ser. No. 08/888,309 filed on Jul. 3, 1997, now U.S. Pat. No. 6,048,734, issued May 2, 2000, which is a Continuation-in-Part of U.S. patent application Ser. No. 08/529,293 filed on Sep. 15, 1995, now U.S. Pat. No. 6,057,149, issued Apr. 11, 2000.

US Referenced Citations (762)
Number Name Date Kind
1434314 Raich Oct 1922 A
1616419 Wilson Feb 1927 A
1733401 Lovekin Aug 1930 A
3528449 Witte et al. Sep 1970 A
3813316 Chakrabarty et al. May 1974 A
3985649 Eddelman Oct 1976 A
4018089 Dzula et al. Apr 1977 A
4018652 Lanham et al. Apr 1977 A
4038192 Serur Jul 1977 A
4055395 Honkawa et al. Oct 1977 A
D249706 Adamski Sep 1978 S
4139005 Dickey Feb 1979 A
D252157 Kronish et al. Jun 1979 S
D252341 Thomas Jul 1979 S
D254687 Fadler et al. Apr 1980 S
4212744 Oota Jul 1980 A
D261033 Armbruster Sep 1981 S
D261173 Armbruster Oct 1981 S
4301412 Hill et al. Nov 1981 A
4439526 Columbus Mar 1984 A
4457329 Werley et al. Jul 1984 A
4466740 Kano et al. Aug 1984 A
4504582 Swann Mar 1985 A
4522786 Ebersole Jun 1985 A
D279817 Chen et al. Jul 1985 S
4599315 Terasaki et al. Jul 1986 A
4612873 Eberle Sep 1986 A
4612959 Costello Sep 1986 A
D288478 Carlson et al. Feb 1987 S
4654127 Baker et al. Mar 1987 A
4673657 Christian Jun 1987 A
4683195 Mullis et al. Jul 1987 A
4683202 Mullis Jul 1987 A
D292735 Lovborg Nov 1987 S
4720374 Ramachandran Jan 1988 A
4798693 Mase et al. Jan 1989 A
4800022 Leonard Jan 1989 A
4841786 Schulz Jun 1989 A
D302294 Hillman Jul 1989 S
4871779 Killat et al. Oct 1989 A
4895650 Wang Jan 1990 A
4919829 Gates et al. Apr 1990 A
4919892 Plumb Apr 1990 A
4921809 Schiff et al. May 1990 A
4935342 Seligson et al. Jun 1990 A
4946562 Guruswamy Aug 1990 A
4949742 Rando et al. Aug 1990 A
D310413 Bigler et al. Sep 1990 S
4963498 Hillman Oct 1990 A
4967950 Legg et al. Nov 1990 A
4978502 Dole et al. Dec 1990 A
4978622 Mishell et al. Dec 1990 A
4989626 Takagi et al. Feb 1991 A
5001417 Pumphrey et al. Mar 1991 A
5004583 Guruswamy et al. Apr 1991 A
5048554 Kremer Sep 1991 A
5053199 Keiser et al. Oct 1991 A
5060823 Perlman Oct 1991 A
5061336 Soane Oct 1991 A
5064618 Baker et al. Nov 1991 A
5071531 Soane Dec 1991 A
5091328 Miller Feb 1992 A
D324426 Fan et al. Mar 1992 S
5096669 Lauks et al. Mar 1992 A
5126002 Iwata et al. Jun 1992 A
5126022 Soane et al. Jun 1992 A
D328135 Fan et al. Jul 1992 S
D328794 Frenkel et al. Aug 1992 S
5135627 Soane Aug 1992 A
5135872 Pouletty et al. Aug 1992 A
5147606 Charlton et al. Sep 1992 A
5160945 Drake Nov 1992 A
5169512 Wiedenmann et al. Dec 1992 A
D333522 Gianino Feb 1993 S
5186339 Heissler Feb 1993 A
5192507 Taylor et al. Mar 1993 A
5208163 Charlton et al. May 1993 A
5223226 Wittmer et al. Jun 1993 A
D338275 Fischer et al. Aug 1993 S
5250263 Manz Oct 1993 A
5252743 Barrett et al. Oct 1993 A
5256376 Callan et al. Oct 1993 A
5275787 Yuguchi et al. Jan 1994 A
5282950 Dietze et al. Feb 1994 A
5296375 Kricka et al. Mar 1994 A
5304477 Nagoh et al. Apr 1994 A
5304487 Wilding et al. Apr 1994 A
D347478 Pinkney May 1994 S
5311896 Kaartinen et al. May 1994 A
5311996 Duffy et al. May 1994 A
5316727 Suzuki et al. May 1994 A
5327038 Culp Jul 1994 A
5339486 Persic Aug 1994 A
D351475 Gerber Oct 1994 S
D351913 Hieb et al. Oct 1994 S
5364591 Green et al. Nov 1994 A
5372946 Cusak et al. Dec 1994 A
5374395 Robinson Dec 1994 A
5385709 Wise et al. Jan 1995 A
5389339 Petschek et al. Feb 1995 A
5397709 Berndt Mar 1995 A
5401465 Smethers et al. Mar 1995 A
5411708 Moscetta et al. May 1995 A
5414245 Hackleman May 1995 A
5416000 Allen et al. May 1995 A
5422271 Chen et al. Jun 1995 A
5422284 Lau Jun 1995 A
5427946 Kricka et al. Jun 1995 A
5474796 Brennan Dec 1995 A
D366116 Biskupski Jan 1996 S
5486335 Wilding et al. Jan 1996 A
5494639 Grzegorzewski Feb 1996 A
5498392 Wilding et al. Mar 1996 A
5503803 Brown Apr 1996 A
5516410 Schneider et al. May 1996 A
5519635 Miyake et al. May 1996 A
5529677 Schneider et al. Jun 1996 A
5533412 Jerman et al. Jul 1996 A
5559432 Logue Sep 1996 A
5565171 Dovichi et al. Oct 1996 A
5569364 Hooper et al. Oct 1996 A
5578270 Reichler et al. Nov 1996 A
5578818 Kain et al. Nov 1996 A
5579928 Anukwuem Dec 1996 A
5580523 Bard Dec 1996 A
5582884 Ball et al. Dec 1996 A
5585069 Zanzucchi et al. Dec 1996 A
5585089 Queen et al. Dec 1996 A
5585242 Bouma et al. Dec 1996 A
5587128 Wilding et al. Dec 1996 A
5589136 Northrup et al. Dec 1996 A
5593838 Zanzucchi et al. Jan 1997 A
5595708 Berndt Jan 1997 A
5599432 Manz et al. Feb 1997 A
5599503 Manz et al. Feb 1997 A
5599667 Arnold et al. Feb 1997 A
5601727 Bormann et al. Feb 1997 A
5603351 Cherukuri et al. Feb 1997 A
5605662 Heller et al. Feb 1997 A
D378782 LaBarbera et al. Apr 1997 S
5628890 Carter et al. May 1997 A
5630920 Friese et al. May 1997 A
5631337 Sassi et al. May 1997 A
5632876 Zanzucchi et al. May 1997 A
5632957 Heller et al. May 1997 A
5635358 Wilding et al. Jun 1997 A
5637469 Wilding et al. Jun 1997 A
5639423 Northrup et al. Jun 1997 A
5643738 Zanzucchi et al. Jul 1997 A
5646039 Northrup et al. Jul 1997 A
5647994 Tuunanen et al. Jul 1997 A
5648482 Meyer Jul 1997 A
5651839 Rauf Jul 1997 A
5652149 Mileaf et al. Jul 1997 A
D382346 Buhler et al. Aug 1997 S
D382647 Staples et al. Aug 1997 S
5667976 Van Ness et al. Sep 1997 A
5671303 Shieh et al. Sep 1997 A
5674394 Whitmore Oct 1997 A
5674742 Northrup et al. Oct 1997 A
5681484 Zanzucchi et al. Oct 1997 A
5681529 Taguchi et al. Oct 1997 A
5683657 Mian Nov 1997 A
5699157 Parce Dec 1997 A
5700637 Southern Dec 1997 A
5705813 Apffel et al. Jan 1998 A
5726026 Wilding et al. Mar 1998 A
5726404 Brody Mar 1998 A
5726944 Pelley et al. Mar 1998 A
5731212 Gavin et al. Mar 1998 A
5744366 Kricka et al. Apr 1998 A
5747666 Willis May 1998 A
5750015 Soane et al. May 1998 A
5755942 Zanzucchi et al. May 1998 A
5763262 Wong et al. Jun 1998 A
5770029 Nelson et al. Jun 1998 A
5770388 Vorpahl Jun 1998 A
5772966 Maracas et al. Jun 1998 A
5779868 Parce et al. Jul 1998 A
5787032 Heller et al. Jul 1998 A
5788814 Sun et al. Aug 1998 A
5800600 Lima-Marques et al. Sep 1998 A
5800690 Chow et al. Sep 1998 A
5804436 Okun et al. Sep 1998 A
D399959 Prokop et al. Oct 1998 S
5827481 Bente et al. Oct 1998 A
5842106 Thaler et al. Nov 1998 A
5842787 Kopf-Sill et al. Dec 1998 A
5846396 Zanzucchi et al. Dec 1998 A
5849208 Hayes et al. Dec 1998 A
5849486 Heller et al. Dec 1998 A
5849489 Heller Dec 1998 A
5849598 Wilson et al. Dec 1998 A
5852495 Parce Dec 1998 A
5856174 Lipshutz et al. Jan 1999 A
5858187 Ramsey et al. Jan 1999 A
5858188 Soane et al. Jan 1999 A
5863502 Southgate et al. Jan 1999 A
5863708 Zanzucchi et al. Jan 1999 A
5863801 Southgate et al. Jan 1999 A
5866345 Wilding et al. Feb 1999 A
5869004 Parce et al. Feb 1999 A
5869244 Martin et al. Feb 1999 A
5872010 Karger et al. Feb 1999 A
5872623 Stabile et al. Feb 1999 A
5874046 Megerle Feb 1999 A
5876675 Kennedy Mar 1999 A
5880071 Parce et al. Mar 1999 A
5882465 McReynolds Mar 1999 A
5883211 Sassi et al. Mar 1999 A
5885432 Hooper et al. Mar 1999 A
5885470 Parce et al. Mar 1999 A
5895762 Greenfield et al. Apr 1999 A
5900130 Benregnu et al. May 1999 A
5912124 Kumar Jun 1999 A
5912134 Shartle Jun 1999 A
5916522 Boyd et al. Jun 1999 A
5916776 Kumar Jun 1999 A
5919646 Okun et al. Jul 1999 A
5919711 Boyd et al. Jul 1999 A
5922591 Anderson et al. Jul 1999 A
5927547 Papen et al. Jul 1999 A
5928880 Wilding et al. Jul 1999 A
5929208 Heller et al. Jul 1999 A
D413391 Lapeus et al. Aug 1999 S
5932799 Moles Aug 1999 A
5935401 Amigo Aug 1999 A
5939291 Loewy et al. Aug 1999 A
5942443 Parce et al. Aug 1999 A
D413677 Dumitrescu et al. Sep 1999 S
5948227 Dubrow Sep 1999 A
5955028 Chow Sep 1999 A
5955029 Wilding et al. Sep 1999 A
5957579 Kopf-Sill et al. Sep 1999 A
5958203 Parce et al. Sep 1999 A
5958694 Nikiforov Sep 1999 A
5959221 Boyd et al. Sep 1999 A
5959291 Jensen Sep 1999 A
5964995 Nikiforov et al. Oct 1999 A
5964997 McBride Oct 1999 A
5965001 Chow et al. Oct 1999 A
5965410 Chow et al. Oct 1999 A
5965886 Sauer et al. Oct 1999 A
5968745 Thorp et al. Oct 1999 A
5972187 Parce et al. Oct 1999 A
5973138 Collis Oct 1999 A
D417009 Boyd Nov 1999 S
5976336 Dubrow et al. Nov 1999 A
5980704 Cherukuri et al. Nov 1999 A
5980719 Cherukuri et al. Nov 1999 A
5981735 Thatcher et al. Nov 1999 A
5989402 Chow et al. Nov 1999 A
5992820 Fare et al. Nov 1999 A
5993611 Moroney et al. Nov 1999 A
5993750 Ghosh et al. Nov 1999 A
5997708 Craig Dec 1999 A
6001229 Ramsey Dec 1999 A
6001231 Kopf-Sill Dec 1999 A
6001307 Naka et al. Dec 1999 A
6004515 Parce et al. Dec 1999 A
6007690 Nelson et al. Dec 1999 A
6010607 Ramsey Jan 2000 A
6010608 Ramsey Jan 2000 A
6010627 Hood Jan 2000 A
6012902 Parce Jan 2000 A
D420747 Dumitrescu et al. Feb 2000 S
D421130 Cohen et al. Feb 2000 S
6024920 Cunanan Feb 2000 A
D421653 Purcell Mar 2000 S
6033546 Ramsey Mar 2000 A
6043080 Lipshutz et al. Mar 2000 A
6046056 Parce et al. Apr 2000 A
6048734 Burns et al. Apr 2000 A
6054034 Soane et al. Apr 2000 A
6054277 Furcht et al. Apr 2000 A
6056860 Amigo et al. May 2000 A
6057149 Burns et al. May 2000 A
6062261 Jacobson et al. May 2000 A
6063341 Fassbind et al. May 2000 A
6063589 Kellogg et al. May 2000 A
6068752 Dubrow et al. May 2000 A
6071478 Chow Jun 2000 A
6074725 Kennedy Jun 2000 A
6074827 Nelson et al. Jun 2000 A
D428497 Lapeus et al. Jul 2000 S
6086740 Kennedy Jul 2000 A
6096509 Okun et al. Aug 2000 A
6100541 Nagle et al. Aug 2000 A
6102897 Lang Aug 2000 A
6103537 Ullman et al. Aug 2000 A
6106685 McBride et al. Aug 2000 A
6110343 Ramsey et al. Aug 2000 A
6123205 Dumitrescu et al. Sep 2000 A
6123798 Gandhi et al. Sep 2000 A
6130098 Handique et al. Oct 2000 A
6132580 Mathies et al. Oct 2000 A
6132684 Marino Oct 2000 A
6133436 Koster et al. Oct 2000 A
D433759 Mathis et al. Nov 2000 S
6143250 Tajima Nov 2000 A
6149787 Chow et al. Nov 2000 A
6156199 Zuk Dec 2000 A
6158269 Dorenkott et al. Dec 2000 A
6167910 Chow Jan 2001 B1
6168948 Anderson et al. Jan 2001 B1
6171850 Nagle et al. Jan 2001 B1
6174675 Chow et al. Jan 2001 B1
6180950 Olsen Jan 2001 B1
D438311 Yamanishi et al. Feb 2001 S
6190619 Kilcoin et al. Feb 2001 B1
D438632 Miller Mar 2001 S
D438633 Miller Mar 2001 S
6197595 Anderson et al. Mar 2001 B1
6211989 Wulf et al. Apr 2001 B1
6213151 Jacobson et al. Apr 2001 B1
6221600 MacLeod et al. Apr 2001 B1
6228635 Armstrong et al. May 2001 B1
6232072 Fisher May 2001 B1
6235175 Dubrow et al. May 2001 B1
6235313 Mathiowitz et al. May 2001 B1
6235471 Knapp et al. May 2001 B1
6236456 Giebeler et al. May 2001 B1
6236581 Foss et al. May 2001 B1
6251343 Dubrow et al. Jun 2001 B1
6254826 Acosta et al. Jul 2001 B1
6259635 Khouri et al. Jul 2001 B1
6261431 Mathies et al. Jul 2001 B1
6267858 Parce et al. Jul 2001 B1
D446306 Ochi et al. Aug 2001 S
6271021 Burns et al. Aug 2001 B1
6274089 Chow et al. Aug 2001 B1
6280967 Ransom et al. Aug 2001 B1
6281008 Komai et al. Aug 2001 B1
6284113 Bjornson et al. Sep 2001 B1
6287254 Dodds Sep 2001 B1
6287774 Kikiforov Sep 2001 B1
6291248 Haj-Ahmad Sep 2001 B1
6294063 Becker et al. Sep 2001 B1
6302134 Kellogg et al. Oct 2001 B1
6302304 Spencer Oct 2001 B1
6303343 Kopf-Sill Oct 2001 B1
6306273 Wainright et al. Oct 2001 B1
6306590 Mehta et al. Oct 2001 B1
6319469 Mian et al. Nov 2001 B1
6322683 Wolk et al. Nov 2001 B1
6326083 Yang et al. Dec 2001 B1
6326211 Anderson et al. Dec 2001 B1
6334980 Hayes et al. Jan 2002 B1
6337435 Chu et al. Jan 2002 B1
6353475 Jensen et al. Mar 2002 B1
6358387 Kopf-Sill et al. Mar 2002 B1
6366924 Parce Apr 2002 B1
6368871 Christel et al. Apr 2002 B1
6370206 Schenk Apr 2002 B1
6375185 Lin Apr 2002 B1
6375901 Robotti et al. Apr 2002 B1
6379884 Wada et al. Apr 2002 B2
6379929 Burns et al. Apr 2002 B1
6379974 Parce et al. Apr 2002 B1
6382254 Yang et al. May 2002 B1
6391541 Petersen et al. May 2002 B1
6391623 Besemer et al. May 2002 B1
6395161 Schneider et al. May 2002 B1
6398956 Coville et al. Jun 2002 B1
6399025 Chow Jun 2002 B1
6399389 Parce et al. Jun 2002 B1
6399952 Maher et al. Jun 2002 B1
6401552 Elkins Jun 2002 B1
6403338 Knapp et al. Jun 2002 B1
6408878 Unger et al. Jun 2002 B2
6413401 Chow et al. Jul 2002 B1
6416642 Alajoki et al. Jul 2002 B1
6420143 Kopf-Sill Jul 2002 B1
6425972 McReynolds Jul 2002 B1
D461906 Pham Aug 2002 S
6428987 Franzen Aug 2002 B2
6430512 Gallagher Aug 2002 B1
6432366 Ruediger et al. Aug 2002 B2
6440725 Pourahmadi et al. Aug 2002 B1
D463031 Slomski et al. Sep 2002 S
6444461 Knapp et al. Sep 2002 B1
6447661 Chow et al. Sep 2002 B1
6447727 Parce et al. Sep 2002 B1
6448064 Vo-Dinh et al. Sep 2002 B1
6453928 Kaplan et al. Sep 2002 B1
6465257 Parce et al. Oct 2002 B1
6468761 Yang et al. Oct 2002 B2
6472141 Nikiforov Oct 2002 B2
6475364 Dubrow et al. Nov 2002 B1
D467348 McMichael et al. Dec 2002 S
D467349 Niedbala et al. Dec 2002 S
6488897 Dubrow et al. Dec 2002 B2
6495104 Unno et al. Dec 2002 B1
6498497 Chow et al. Dec 2002 B1
6500323 Chow et al. Dec 2002 B1
6500390 Boulton et al. Dec 2002 B1
D468437 McMenamy et al. Jan 2003 S
6506609 Wada et al. Jan 2003 B1
6509193 Tajima Jan 2003 B1
6511853 Kopf-Sill et al. Jan 2003 B1
D470595 Crisanti et al. Feb 2003 S
6515753 Maher Feb 2003 B2
6517783 Horner et al. Feb 2003 B2
6520197 Deshmukh et al. Feb 2003 B2
6521188 Webster Feb 2003 B1
6524456 Ramsey et al. Feb 2003 B1
6524790 Kopf-Sill et al. Feb 2003 B1
D472324 Rumore et al. Mar 2003 S
6534295 Tai et al. Mar 2003 B2
6537771 Farinas et al. Mar 2003 B1
6540896 Manz et al. Apr 2003 B1
6544734 Briscoe et al. Apr 2003 B1
6547942 Parce et al. Apr 2003 B1
6555389 Ullman et al. Apr 2003 B1
6556923 Gallagher et al. Apr 2003 B2
D474279 Mayer et al. May 2003 S
D474280 Niedbala et al. May 2003 S
6558916 Veerapandian et al. May 2003 B2
6558945 Kao May 2003 B1
6569607 McReynolds May 2003 B2
6572830 Burdon et al. Jun 2003 B1
6575188 Parunak Jun 2003 B2
6576459 Miles et al. Jun 2003 B2
6579453 Bächler et al. Jun 2003 B1
6589729 Chan et al. Jul 2003 B2
6592821 Wada et al. Jul 2003 B1
6597450 Andrews et al. Jul 2003 B1
6602474 Tajima Aug 2003 B1
6613211 McCormick et al. Sep 2003 B1
6613512 Kopf-sill et al. Sep 2003 B1
6613580 Chow et al. Sep 2003 B1
6613581 Wada et al. Sep 2003 B1
6614030 Maher et al. Sep 2003 B2
6620625 Wolk et al. Sep 2003 B2
6623860 Hu et al. Sep 2003 B2
6627406 Singh et al. Sep 2003 B1
D480814 Lafferty et al. Oct 2003 S
6632655 Mehta et al. Oct 2003 B1
6633785 Kasahara et al. Oct 2003 B1
D482796 Oyama et al. Nov 2003 S
6649358 Parce et al. Nov 2003 B1
6664104 Pourahmadi et al. Dec 2003 B2
6669831 Chow et al. Dec 2003 B2
6670153 Stern Dec 2003 B2
D484989 Gebrian Jan 2004 S
6681616 Spaid et al. Jan 2004 B2
6681788 Parce et al. Jan 2004 B2
6685813 Williams et al. Feb 2004 B2
6692700 Handique Feb 2004 B2
6695009 Chien et al. Feb 2004 B2
6706519 Kellogg et al. Mar 2004 B1
6720148 Nikiforov Apr 2004 B1
6730206 Ricco et al. May 2004 B2
6733645 Chow May 2004 B1
6734401 Bedingham et al. May 2004 B2
6737026 Bergh et al. May 2004 B1
6740518 Duong et al. May 2004 B1
D491272 Alden et al. Jun 2004 S
D491273 Biegler et al. Jun 2004 S
D491276 Langille Jun 2004 S
6750661 Brooks et al. Jun 2004 B2
6752966 Chazan Jun 2004 B1
6756019 Dubrow et al. Jun 2004 B1
6766817 da Silva Jul 2004 B2
6773567 Wolk Aug 2004 B1
6777184 Nikiforov et al. Aug 2004 B2
6783962 Olander et al. Aug 2004 B1
D495805 Lea et al. Sep 2004 S
6787015 Lackritz et al. Sep 2004 B2
6787016 Tan et al. Sep 2004 B2
6790328 Jacobson et al. Sep 2004 B2
6790330 Gascoyne et al. Sep 2004 B2
6811668 Berndt et al. Nov 2004 B1
6818113 Williams et al. Nov 2004 B2
6819027 Saraf Nov 2004 B2
6824663 Boone Nov 2004 B1
D499813 Wu Dec 2004 S
D500142 Crisanti et al. Dec 2004 S
6827831 Chow et al. Dec 2004 B1
6827906 Bjornson et al. Dec 2004 B1
6838156 Neyer et al. Jan 2005 B1
6838680 Maher et al. Jan 2005 B2
6852287 Ganesan Feb 2005 B2
6858185 Kopf-sill et al. Feb 2005 B1
6859698 Schmeisser Feb 2005 B2
6861035 Pham et al. Mar 2005 B2
6878540 Pourahmadi et al. Apr 2005 B2
6878755 Singh et al. Apr 2005 B2
6884628 Hubbell et al. Apr 2005 B2
6887693 McMillan et al. May 2005 B2
6893879 Petersen et al. May 2005 B2
6900889 Bjornson et al. May 2005 B2
6905583 Wainright et al. Jun 2005 B2
6905612 Dorian et al. Jun 2005 B2
6906797 Kao et al. Jun 2005 B1
6908594 Schaevitz et al. Jun 2005 B1
6911183 Handique et al. Jun 2005 B1
6914137 Baker Jul 2005 B2
6915679 Chien et al. Jul 2005 B2
6918404 Dias da Silva Jul 2005 B2
D508999 Fanning et al. Aug 2005 S
6939451 Zhao et al. Sep 2005 B2
6942771 Kayyem Sep 2005 B1
6958392 Fomovskaia et al. Oct 2005 B2
D512155 Matsumoto Nov 2005 S
6964747 Banerjee et al. Nov 2005 B2
6977163 Mehta Dec 2005 B1
6984516 Briscoe et al. Jan 2006 B2
D515707 Shinohara et al. Feb 2006 S
D516221 Wohlstadter et al. Feb 2006 S
7001853 Brown et al. Feb 2006 B1
7004184 Handique et al. Feb 2006 B2
D517554 Yanagisawa et al. Mar 2006 S
7010391 Handique et al. Mar 2006 B2
7023007 Gallagher Apr 2006 B2
7024281 Unno Apr 2006 B1
7036667 Greenstein et al. May 2006 B2
7037416 Parce et al. May 2006 B2
7038472 Chien May 2006 B1
7039527 Tripathi et al. May 2006 B2
7040144 Spaid et al. May 2006 B2
D523153 Akashi et al. Jun 2006 S
7055695 Greenstein et al. Jun 2006 B2
7060171 Nikiforov et al. Jun 2006 B1
7066586 da Silva Jun 2006 B2
7069952 McReynolds et al. Jul 2006 B1
7099778 Chien Aug 2006 B2
D528215 Malmsater Sep 2006 S
7101467 Spaid Sep 2006 B2
7105304 Nikiforov et al. Sep 2006 B1
D531321 Godfrey et al. Oct 2006 S
7118910 Unger et al. Oct 2006 B2
7138032 Gandhi et al. Nov 2006 B2
D534280 Gomm et al. Dec 2006 S
7148043 Kordunsky et al. Dec 2006 B2
7150814 Parce et al. Dec 2006 B1
7150999 Shuck Dec 2006 B1
D535403 Isozaki et al. Jan 2007 S
7160423 Chien et al. Jan 2007 B2
7161356 Chien Jan 2007 B1
7169277 Ausserer et al. Jan 2007 B2
7169618 Skold Jan 2007 B2
D537951 Okamoto et al. Mar 2007 S
D538436 Patadia et al. Mar 2007 S
7192557 Wu et al. Mar 2007 B2
7195036 Burns et al. Mar 2007 B2
7195986 Bousse et al. Mar 2007 B1
7208125 Dong Apr 2007 B1
7235406 Woudenberg et al. Jun 2007 B1
7247274 Chow Jul 2007 B1
D548841 Brownell et al. Aug 2007 S
D549827 Maeno et al. Aug 2007 S
7252928 Hafeman et al. Aug 2007 B1
7270786 Parunak et al. Sep 2007 B2
D554069 Bolotin et al. Oct 2007 S
D554070 Bolotin et al. Oct 2007 S
7276330 Chow et al. Oct 2007 B2
D556914 Okamoto et al. Dec 2007 S
7303727 Dubrow et al. Dec 2007 B1
D559995 Handique et al. Jan 2008 S
7323140 Handique et al. Jan 2008 B2
7332130 Handique Feb 2008 B2
7338760 Gong et al. Mar 2008 B2
D566291 Parunak et al. Apr 2008 S
7351377 Chazan et al. Apr 2008 B2
D569526 Duffy et al. May 2008 S
7374949 Kuriger May 2008 B2
7390460 Osawa et al. Jun 2008 B2
7419784 Dubrow et al. Sep 2008 B2
7422669 Jacobson et al. Sep 2008 B2
7440684 Spaid et al. Oct 2008 B2
7476313 Siddiqi Jan 2009 B2
7494577 Williams et al. Feb 2009 B2
7494770 Wilding et al. Feb 2009 B2
7514046 Kechagia et al. Apr 2009 B2
7518726 Rulison et al. Apr 2009 B2
7521186 Burd Apr 2009 B2
7527769 Bunch et al. May 2009 B2
D595423 Johansson et al. Jun 2009 S
7553671 Sinclair et al. Jun 2009 B2
D596312 Giraud et al. Jul 2009 S
D598566 Allaer Aug 2009 S
D599234 Ito Sep 2009 S
7595197 Brasseur Sep 2009 B2
7604938 Takahashi et al. Oct 2009 B2
7635588 King et al. Dec 2009 B2
7645581 Knapp et al. Jan 2010 B2
7670559 Chien et al. Mar 2010 B2
7674431 Ganesan Mar 2010 B2
7704735 Facer et al. Apr 2010 B2
7723123 Murphy et al. May 2010 B1
D618820 Wilson et al. Jun 2010 S
7727371 Kennedy et al. Jun 2010 B2
7727477 Boronkay et al. Jun 2010 B2
7744817 Bui Jun 2010 B2
D621060 Handique Aug 2010 S
7867776 Kennedy et al. Jan 2011 B2
D632799 Canner et al. Feb 2011 S
7892819 Wilding et al. Feb 2011 B2
7998708 Handique et al. Aug 2011 B2
8088616 Handique Jan 2012 B2
8105783 Handique Jan 2012 B2
8133671 Williams et al. Mar 2012 B2
8182763 Duffy et al. May 2012 B2
8287820 Williams et al. Oct 2012 B2
8323584 Ganesan Dec 2012 B2
8323900 Handique et al. Dec 2012 B2
8324372 Brahmasandra et al. Dec 2012 B2
20010023848 Gjerde et al. Sep 2001 A1
20010038450 McCaffrey et al. Nov 2001 A1
20010046702 Schembri Nov 2001 A1
20010055765 O'Keefe et al. Dec 2001 A1
20020001848 Bedingham et al. Jan 2002 A1
20020008053 Hansen et al. Jan 2002 A1
20020009015 Laugharn et al. Jan 2002 A1
20020015667 Chow Feb 2002 A1
20020021983 Comte et al. Feb 2002 A1
20020037499 Quake et al. Mar 2002 A1
20020039783 McMillan et al. Apr 2002 A1
20020053399 Soane et al. May 2002 A1
20020054835 Robotti et al. May 2002 A1
20020055167 Pourahmadi et al. May 2002 A1
20020058332 Quake et al. May 2002 A1
20020060156 Mathies et al. May 2002 A1
20020068357 Mathies et al. Jun 2002 A1
20020141903 Parunak et al. Oct 2002 A1
20020142471 Handique et al. Oct 2002 A1
20020143297 Francavilla et al. Oct 2002 A1
20020143437 Handique et al. Oct 2002 A1
20020155477 Ito Oct 2002 A1
20020169518 Luoma et al. Nov 2002 A1
20020187557 Hobbs et al. Dec 2002 A1
20030019522 Parunak Jan 2003 A1
20030049833 Chen et al. Mar 2003 A1
20030064507 Gallagher et al. Apr 2003 A1
20030070677 Handique et al. Apr 2003 A1
20030073106 Johansen et al. Apr 2003 A1
20030083686 Freeman et al. May 2003 A1
20030087300 Knapp et al. May 2003 A1
20030127327 Kurnik Jul 2003 A1
20030136679 Bohn et al. Jul 2003 A1
20030186295 Colin et al. Oct 2003 A1
20030199081 Wilding et al. Oct 2003 A1
20030211517 Carulli et al. Nov 2003 A1
20040014238 Krug et al. Jan 2004 A1
20040029258 Heaney et al. Feb 2004 A1
20040029260 Hansen et al. Feb 2004 A1
20040037739 McNeely et al. Feb 2004 A1
20040053290 Terbrueggen et al. Mar 2004 A1
20040063217 Webster et al. Apr 2004 A1
20040072278 Chou et al. Apr 2004 A1
20040072375 Gjerde et al. Apr 2004 A1
20040086956 Bachur May 2004 A1
20040141887 Mainquist et al. Jul 2004 A1
20040151629 Pease et al. Aug 2004 A1
20040157220 Kurnool et al. Aug 2004 A1
20040161788 Chen et al. Aug 2004 A1
20040189311 Glezer et al. Sep 2004 A1
20040200909 McMillan et al. Oct 2004 A1
20040209331 Ririe Oct 2004 A1
20040209354 Mathies et al. Oct 2004 A1
20040219070 Handique Nov 2004 A1
20040240097 Evans Dec 2004 A1
20050009174 Nikiforov et al. Jan 2005 A1
20050041525 Pugia et al. Feb 2005 A1
20050048540 Inami et al. Mar 2005 A1
20050058574 Bysouth et al. Mar 2005 A1
20050084424 Ganesan et al. Apr 2005 A1
20050106066 Saltsman et al. May 2005 A1
20050121324 Park et al. Jun 2005 A1
20050133370 Park et al. Jun 2005 A1
20050135655 Kopf-Sill et al. Jun 2005 A1
20050152808 Ganesan Jul 2005 A1
20050170362 Wada et al. Aug 2005 A1
20050186585 Juncosa et al. Aug 2005 A1
20050202470 Sundberg et al. Sep 2005 A1
20050202504 Anderson et al. Sep 2005 A1
20050208676 Kahatt Sep 2005 A1
20050220675 Reed et al. Oct 2005 A1
20050227269 Lloyd et al. Oct 2005 A1
20050233370 Ammann et al. Oct 2005 A1
20050238545 Parce et al. Oct 2005 A1
20050272079 Burns et al. Dec 2005 A1
20060041058 Yin et al. Feb 2006 A1
20060057039 Morse et al. Mar 2006 A1
20060057629 Kim Mar 2006 A1
20060062696 Chow et al. Mar 2006 A1
20060094108 Yoder et al. May 2006 A1
20060113190 Kurnik Jun 2006 A1
20060133965 Tajima et al. Jun 2006 A1
20060134790 Tanaka et al. Jun 2006 A1
20060148063 Fauzzi et al. Jul 2006 A1
20060165558 Witty et al. Jul 2006 A1
20060165559 Greenstein et al. Jul 2006 A1
20060166233 Wu et al. Jul 2006 A1
20060177376 Tomalia et al. Aug 2006 A1
20060177855 Utermohlen et al. Aug 2006 A1
20060183216 Handique Aug 2006 A1
20060207944 Siddiqi Sep 2006 A1
20060246493 Jensen et al. Nov 2006 A1
20060246533 Fathollahi et al. Nov 2006 A1
20070004028 Lair et al. Jan 2007 A1
20070009386 Padmanabhan et al. Jan 2007 A1
20070020699 Carpenter et al. Jan 2007 A1
20070026421 Sundberg et al. Feb 2007 A1
20070042441 Masters et al. Feb 2007 A1
20070092901 Ligler et al. Apr 2007 A1
20070098600 Kayyem et al. May 2007 A1
20070099200 Chow et al. May 2007 A1
20070104617 Coulling et al. May 2007 A1
20070154895 Spaid et al. Jul 2007 A1
20070177147 Parce Aug 2007 A1
20070178607 Prober et al. Aug 2007 A1
20070184463 Molho et al. Aug 2007 A1
20070184547 Handique et al. Aug 2007 A1
20070196238 Kennedy et al. Aug 2007 A1
20070199821 Chow Aug 2007 A1
20070215554 Kreuwel et al. Sep 2007 A1
20070218459 Miller et al. Sep 2007 A1
20070231213 Prabhu et al. Oct 2007 A1
20070261479 Spaid et al. Nov 2007 A1
20070269861 Williams et al. Nov 2007 A1
20070292941 Handique et al. Dec 2007 A1
20080000774 Park et al. Jan 2008 A1
20080050804 Handique et al. Feb 2008 A1
20080056948 Dale et al. Mar 2008 A1
20080075634 Herchenbach et al. Mar 2008 A1
20080090244 Knapp et al. Apr 2008 A1
20080095673 Xu Apr 2008 A1
20080118987 Eastwood et al. May 2008 A1
20080124723 Dale et al. May 2008 A1
20080149840 Handique et al. Jun 2008 A1
20080160601 Handique Jul 2008 A1
20080182301 Handique et al. Jul 2008 A1
20080192254 Kim et al. Aug 2008 A1
20080247914 Edens et al. Oct 2008 A1
20080262213 Wu et al. Oct 2008 A1
20090047713 Handique Feb 2009 A1
20090129978 Wilson et al. May 2009 A1
20090130719 Handique May 2009 A1
20090130745 Williams et al. May 2009 A1
20090131650 Brahmasandra et al. May 2009 A1
20090134069 Handique May 2009 A1
20090136385 Handique et al. May 2009 A1
20090136386 Duffy et al. May 2009 A1
20090155123 Williams et al. Jun 2009 A1
20090189089 Bedingham et al. Jul 2009 A1
20090221059 Williams et al. Sep 2009 A1
20090223925 Morse et al. Sep 2009 A1
20100009351 Brahmasandra et al. Jan 2010 A1
20100173393 Handique et al. Jul 2010 A1
20110020876 Wilding et al. Jan 2011 A1
20110027151 Handique et al. Feb 2011 A1
20110207140 Handique et al. Aug 2011 A1
20110210257 Handique et al. Sep 2011 A9
20120022695 Handique et al. Jan 2012 A1
20120085416 Ganesan Apr 2012 A1
20120122108 Handique May 2012 A1
20120160826 Handique Jun 2012 A1
20120171759 Williams et al. Jul 2012 A1
20120183454 Handique Jul 2012 A1
20120258463 Duffy et al. Oct 2012 A1
Foreign Referenced Citations (54)
Number Date Country
2294819 Jan 1999 CA
19929734 Dec 1999 DE
0766256 Apr 1997 EP
1745153 Jan 2007 EP
2672301 Jul 1992 FR
2672301 Aug 1992 FR
2795426 Dec 2000 FR
58212921 Dec 1983 JP
58212921 Dec 1983 JP
H07-290706 Nov 1995 JP
2001-502790 Jan 1998 JP
2000-514928 Apr 1999 JP
2001-509437 Jul 2001 JP
2001-515216 Sep 2001 JP
2001-527220 Dec 2001 JP
2002-215241 Jul 2002 JP
2003-500674 Jan 2003 JP
2005-514718 May 2005 JP
2005-204661 Aug 2005 JP
2005-291954 Oct 2005 JP
WO 8806633 Sep 1988 WO
WO 9012350 Oct 1990 WO
WO 9205443 Apr 1992 WO
WO 9705492 Feb 1997 WO
WO 9800231 Jan 1998 WO
WO 9822625 May 1998 WO
WO 9853311 Nov 1998 WO
WO 9901688 Jan 1999 WO
WO 9909042 Feb 1999 WO
WO 9912016 Mar 1999 WO
WO 9933559 Jul 1999 WO
WO 0105510 Jan 2001 WO
WO 0114931 Mar 2001 WO
WO 0127614 Apr 2001 WO
WO 0128684 Apr 2001 WO
WO 0141931 Jun 2001 WO
WO 0154813 Aug 2001 WO
WO 0189681 Nov 2001 WO
WO 02072264 Sep 2002 WO
WO 02078845 Oct 2002 WO
WO 03012325 Feb 2003 WO
WO 03012406 Feb 2003 WO
WO 03048295 Jun 2003 WO
WO 03055605 Jul 2003 WO
WO 2004007081 Jan 2004 WO
WO 2004074848 Sep 2004 WO
WO 2005011867 Feb 2005 WO
WO 2005108620 Nov 2005 WO
WO 2006079082 Jul 2006 WO
WO 2007050327 May 2007 WO
WO 2008030914 Mar 2008 WO
WO 2008060604 May 2008 WO
WO 2009012185 Jan 2009 WO
WO 2010118541 Oct 2010 WO
Non-Patent Literature Citations (75)
Entry
Marmur and Lane “Strand Separation and Specific Recombination in Deoxyribonucleic Acids: Biological Studies”, Proc.Nat.Acad.Sci, U.S.A. 46:453-461 (1960).
Doty et et., “Strand Separation and Specific Recombination in Deoxyribonucleic Acids:Physical Chemical Studies”, Proc.Nat.Acad.Sci., U.S.A. 46:461-477 (1960).
Hayashi et al.,“Restriction of in Vivo Genetic Transcription to one of the Complementary Strands of DNA”, Proc.Nat.Acad.Sci., U.S.A. 50:664-6671 (1963).
Smith and Wilcox, “A Restriction Enzyme from Hemophilia influenzae”, J.Mol.Biol. 51:379-391 (1970).
Southern, “Detection of Specific Sequences Among DNA Fragments Separated by Gel Electrophoresis”, J.Mol.Biol. 98:503-517 (1975).
Maxam and Gilbert, “A new method for sequencing DNA”, Proc. Natl. Acad Sci. USA 74:560-564(1977).
Sanger et al., “DNA sequencing with chain-terminating inhibitors”, Proc. Natl. Acad Sci. USA 74:5463-5467 (1977).
Chen and Seeburg, “Laboratory Methods Supercoil Sequencing: A Fast and Simple Method for Sequencing Plasmid DNA”, DNA 4(2):165-170 (1985).
Graham et al., “Direct DNA sequencing using avian myeloblastosis virus and Moleney murine leukemia virus reverse transcriptase”, Bethesda Res. Lab. Focus 8(2):;4 (1986).
Sambrook, J. et al., Molecular Cloning, A Laboratory Manual, 2d Ed. Cold Spring Harbor Laboratory Press, New York, 13.7-13.9.
Hunkapiller, M.W., “Advances in DNA sequencing technology”, Curr. Op. Gen. Devl. 1:88-92 (1991).
Tabor et al., “DNA sequence analysis with a modified bacteriophage T7 DNA polymerase”, Proc. Natl. Acad. Sci. USA 84:4767-4771 (1987).
Innis et al., “DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA”, Proc. Natl. Acad. Sci. USA 85:9436-9440 (1988).
J. Pfahler et al.,“Liquid Transport in Micron and Submicron Channels”, Sensors and Actuators A21-A23: 431-434 (1990).
H.T.G. Van Lintel et at., “A Piezoelectric Micropump Based on Micromachining of Silicon”, Sensors and Actuators 15:153-167 (1988).
Smits, “Piezoelectric Micropump with Three Valves Working Peristaltically,” Sensors and Actuators A21-A23:203-206 (1990).
Mullis and Faloona, “Specific Synthesis of DNA in Vitro via a Polymerase-Catalyzed Chain Reaction,” Meth. Enzym. 155:335-350 (1987).
Amheim, “Polymerase Chain Reaction Strategy,” Annu. Rev. Biochem. 61:131-156 (1992).
Nickerson et al., “Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay,” Proc. Nat. Acad. Sci. USA 87:8923-8927 (1990).
Gordon et al., “Capillary Electrophoresis,” Science 27:224-228 (1988).
Lawrence Berkeley Lab Presentation, Park City, Utah (1993).
Turner, “New Dimensions in Capillary Electrophoresis Columns,” LC-GC vol. 9 (1991).
Heller and Tullis, “Microelectrophoresis for the separation of DNA fragments,” Electrophoresis 13:512-520 (1992).
Manz et al., “Planar chips technology for miniaturization and integration of separation techniques into monitoring systems Capillary electrophoresis on a chip,”J. Chrom. 593:253-258 (1992).
Jorgenson and Lukacs, “High-Resolution Separations Based on Electrophoresis and Electroosmosis,” J. Chrom. 218:209-216 (1981).
Chamberlain et al., “BRCA1 Maps Proximal to D17S579 on Chromosome 17q21 by Genetic Analysis,” Am. J. Hum. Genet. 52:792-798 (1993).
Ansorge et el., “High-throughput automated DNA sequencing facility with fluorescent labels at the European Molecular Biology Laboratory,” Electrophoresis 13:616-619 (1992).
Pentoney et al., “A single-fluor approach to DNA sequence determination using high performance capillary electrophoresis,” Electrophoresis 13:467-474 (1992).
Tenan et al., “Friction in Capillary Systems,” Journal of Applied Physics 53:6687-6692 (1982).
Dussan, “On the Spreading of Liquids on Solid Surfaces Static and Dynamic Contact Lines,” Annual Review of Fluid Mechanics 11:371-400 (1979).
Probstein, “Physicochemical Hydrodynamics,” (1989).
R.F. Service, “The Incredible Shrinking Laboratory,” Science 268:26-27 (1995).
Presentation at Cold Spring Harbor (Aug. 31-Sep. 2, 1995).
R. Nowak, “Xeroxing DNA Analysis” Science 268:1135 (1995).
Manz, A. et al., “Electroosmotic pumping and electrophoretic separations for miniaturized chemical analysis systems” J. Microntech. Microeng. 4:257-265 (1994).
Wooley and Mathies, “Ultra-High-Speed DNA Sequencing Using Capillary Electrophoresis Chips,” Anal. Chem.67:3676-3680 (1995).
Effenhauser et al., “Manipulation of Sample Fractions on a Capillary Electrophoresis Chip,” Anal. Chem. 67:2284-2287 (1995).
Van der Moolen, J.N. et al., “A Micromachined Injection Device for CZE: Application to Correlation CZE” Anal. Chem., 69:4220-4225 (1997).
P.B. Hieptas et al., “Ultrathin Slab Gel Separations of DNA Using Single Capillary Sample Introduction System,” Anal. Chem. 69:2292-2298 (1997).
Z. Liang et al.,“Microfabrication of a Planar Absorbance and Florescence and Fluorescence Cell for Integrated Capillary Electrophoresis Devices,” Anal. Chen?. 68:1040-1046 (1996).
U.S. Appl. No. 10/246,814, filed Sep. 1, 2002, Handique et al.
U.S. Appl. No. 11/929,877, filed Oct. 30, 2007, Ganesan et al.
Bollet, C. et al., “A simple method for the isolation of chromosomal DNA from Gram positive or acid-fast bacteria”, Nucleic Acids Research, vol. 19, No. 8 (1991), p. 1955.
Brahmassandra, et al., On-Chip DNA Detection in Microfabricated Separation Systems, Part of the SPIE Conference on Microfludic Devices and Systems, 1998, Santa Clara, California, vol. 3515, pp. 242-251.
Breadmore, M.C. et al., “Microchip-Based Purification of DNA from Biological Samples”, Anal. Chem., vol. 75 (2003), pp. 1880-1886.
Brody, et al., Diffusion-Based Extraction in a Microfabricated Device, Sensors and Actuators Elsevier, 1997, vol. A58, No. 1, pp. 13-18.
Broyles et al., “Sample Filtration, Concentration, and Separation Integrated on Microfluidic Devices” Analytical Chemistry (American Chemical Society), (2003) 75(11): 2761-2767.
Burns et al., “An Integrated Nanoliter DNA Analysis Device”, Science 282:484-487 (1998).
Carlen et al., “Paraffin Actuated Surface Micromachined Valve,” in IEEE MEMS 2000 Conference, Miyazaki, Japan, (Jan. 2000) pp. 381-385.
Chung et al., “Microfluidic chip for high efficiency DNA extraction”, Miniaturisation for Chemistry, Biology & Bioengineering, vol. 4, No. 2 (Apr. 2004), pp. 141-147.
Handique et al., On-Chip Thermopneumatic Pressure for Discrete Drop Pumping, Analytical Chemistry, American Chemical Society, Apr. 15, 2001, vol. 73, No. 8, 1831-1838.
Handique et al, “Microfluidic flow control using selective hydrophobic patterning”, SPIE, vol. 3224, pp. 185-194 (1997).
Handique et al., “Nanoliter-volume discrete drop injection and pumping in microfabricated chemical analysis systems”, Solid-State Sensor and Actuator Workshop (Hilton Head, South Carolina, Jun. 8-11, 1998) pp. 346-349.
Handique et al., “Mathematical Modeling of Drop Mixing in a Slit-Type Microchannel”, J. Micromech. Microeng., 11:548-554 (2001).
Handique et al., “Nanoliter Liquid Metering in Microchannels Using Hydrophobic Patterns”, Anal. Chem., 72:4100-4109 (2000).
He et al., Microfabricated Filters for Microfluidic Analytical Systems, Analytical Chemistry, American Chemical Society, 1999, vol. 71, No. 7, pp. 1464-1468.
Ibrahim, et al., Real-Time Microchip PCR for Detecting Single-Base Differences in Viral and Human DNA, Analytical Chemistry, American Chemical Society, 1998, 70(9): 2013-2017.
Khandurina et al., Microfabricated Porous Membrane Structure for Sample Concentration and Electrophoretic Analysis, Analyt Chem., (1999) 71(9): 1815-1819.
Kopp et al., Chemical Amplification: Continuous-Flow PCR on a Chip, www.sciencemag.org, 1998, vol. 280, pp. 1046-1048.
Kutter et al., Solid Phase Extraction on Microfluidic Devices, J. Microcolumn Separations, John Wiley & Sons, Inc., 2000, 12(2): 93-97.
Lagally et al., Single-Molecule DNA Amplification and Analysis in an Integrated Microfluidic Device, Analytical Chemistry, American Chemical Society, 2001, 73(3): 565-570.
Livache, et al., “Polypyrrole DNA Chip on a Silison Device: Example of Hepatitis C Virus Genotyping,” Analytical Biochemistry, 1998, vol. 255, pp. 188-194.
Mascini et al., “DNA electrochemical biosensors”, Fresenius J. Anal. Chem., 369: 15-22, (2001).
Northrup et al., A Miniature Analytical Instrument for Nucleic Acids Based on Micromachined Silicon Reaction Chambers, Analytical Chemistry, American Chemical Society, 1998, 70(5): 918-922.
Oleschuk et al., Trapping of Bead-Based Reagents within Microfluidic Systems,: On-Chip Solid-Phase Extraction and Electrochromatography, Analytical Chemistry, American Chemical Society, 2000, 72(3): 585-590.
Plambeck et al., “Electrochemical Studies of Antitumor Antibiotics”, J. Electrochem Soc.: Electrochemical Science and Technology (1984), 131(11): 2556-2563.
Roche et al. “Ectodermal commitment of insulin-producing cells derived from mouse embryonic stem cells” Faseb J (2005) 19: 1341-1343.
Ross et al., “Analysis of DNA Fragments from Conventional and Microfabricated PCR Devices Using Delayed Extraction MALDI-TOF Mass Spectrometry”, Analyt Chem. 1998, 70(10): 2067-2073.
Shoffner et al., Chip PCR.I. Surface Passivation of Microfabricated Silicon-Glass Chips for PCR, Nucleic Acids Research, Oxford University Press, 1996, vol. 24, No. 2, 375-379.
Smith et al., “Comparison of Commercial DNA Extraction Kits for Extraction of Bacterial Genomic DNA from Whole-Blood Samples”, Journal of Clinical Microbiology, vol. 41, No. 6 (Jun. 2003), pp. 2440-2443.
Wang, “Survey and Summary, from DNA Biosensors to Gene Chips”, Nucleic Acids Research, 28(16):3011-3016, (2000).
Waters et al., Microchip Device for Cell Lysis, Multiplex PCR Amplification, and Electrophoretic Sizing, Analytical Chemistry, American Chemical Society, 1998, 70(1): 158-162.
Weigl et al., Microfluidic Diffusion-Based Separation and Detection, www.sciencemag.org, 1999, 283: 346-347.
Yoza et al., “Fully Automated DNA Extraction from Blood Using Magnetic Particles Modified with a Hyperbranched Polyamidomine Dendrimer”, Journal of Bioscience and Bioengineering, 2003, 95(1): 1-26.
Yoza et al., DNA extraction using bacterial magnetic particles modified with hyperbranched polyamidoamine dendrimer, Mar. 20, 2003, 101(3): 219-228.
Related Publications (1)
Number Date Country
20120077231 A1 Mar 2012 US
Divisions (1)
Number Date Country
Parent 11119539 Apr 2005 US
Child 13311087 US
Continuations (2)
Number Date Country
Parent 09517680 Mar 2000 US
Child 11119539 US
Parent 08888309 Jul 1997 US
Child 09517680 US
Continuation in Parts (1)
Number Date Country
Parent 08529293 Sep 1995 US
Child 08888309 US